[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 3428
36. Reisinger DM, Shiffer JD, Cognetta AB Jr, Chang Y, Moore PS: Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma. J Am Acad Dermatol; 2010 Sep;63(3):400-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma.
  • BACKGROUND: Merkel cell polyomavirus (MCV) was discovered by digital transcriptome subtraction as a monoclonal infection of Merkel cell carcinoma (MCC) tumors.
  • OBJECTIVE: We sought to directly assay for MCV infection in squamous cell carcinoma (SCC) or basal cell carcinoma (BCC) tumor cells by immunostaining for viral antigen.
  • [MeSH-major] Carcinoma, Basal Cell / virology. Carcinoma, Merkel Cell / virology. Carcinoma, Squamous Cell / virology. Immunocompetence. Skin Neoplasms / virology

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
  • (PMID = 20584559.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA120726; United States / NCI NIH HHS / CA / CA136363
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Polyomavirus Transforming; 0 / DNA, Viral
  •  go-up   go-down


37. Langenheder S, Lindström ES, Tranvik LJ: Structure and function of bacterial communities emerging from different sources under identical conditions. Appl Environ Microbiol; 2006 Jan;72(1):212-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this study was to compare two major hypotheses concerning the formation of bacterial community composition (BCC) at the local scale, i.e., whether BCC is determined by the prevailing local environmental conditions or by "metacommunity processes."

  • COS Scholar Universe. author profiles.
  • Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).
  • Hazardous Substances Data Bank. BENZOIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 2004 Dec 9;432(7018):747-50 [15592411.001]
  • [Cites] Appl Environ Microbiol. 1999 Aug;65(8):3721-6 [10427073.001]
  • [Cites] Appl Environ Microbiol. 2005 Jan;71(1):227-39 [15640192.001]
  • [Cites] Environ Microbiol. 2005 Mar;7(3):301-13 [15683391.001]
  • [Cites] Appl Environ Microbiol. 2005 Dec;71(12):8201-6 [16332803.001]
  • [Cites] FEMS Microbiol Ecol. 2004 Jul 1;49(1):71-82 [19712385.001]
  • [Cites] Appl Environ Microbiol. 2000 Apr;66(4):1692-7 [10742262.001]
  • [Cites] Appl Environ Microbiol. 2000 Jul;66(7):3044-51 [10877804.001]
  • [Cites] Appl Environ Microbiol. 2000 Nov;66(11):5053-65 [11055963.001]
  • [Cites] Appl Environ Microbiol. 2000 Dec;66(12):5448-56 [11097926.001]
  • [Cites] Environ Microbiol. 2000 Apr;2(2):191-201 [11220305.001]
  • [Cites] Microb Ecol. 2003 Feb;45(2):173-82 [12545315.001]
  • [Cites] Appl Environ Microbiol. 2003 Mar;69(3):1442-51 [12620827.001]
  • [Cites] Appl Environ Microbiol. 2003 May;69(5):2555-62 [12732521.001]
  • [Cites] Appl Environ Microbiol. 2003 Jul;69(7):3701-9 [12839735.001]
  • [Cites] Oecologia. 2003 Aug;136(4):489-98 [12836009.001]
  • [Cites] Appl Environ Microbiol. 2003 Sep;69(9):5248-54 [12957910.001]
  • [Cites] Appl Environ Microbiol. 2003 Oct;69(10):5875-83 [14532039.001]
  • [Cites] Oecologia. 2004 Mar;139(1):98-107 [14740289.001]
  • [Cites] Proc Biol Sci. 2004 Jan 22;271(1535):113-22 [15058386.001]
  • [Cites] Appl Environ Microbiol. 2004 Jun;70(6):3425-33 [15184140.001]
  • [Cites] Curr Opin Microbiol. 2004 Jun;7(3):221-6 [15196488.001]
  • [Cites] Appl Environ Microbiol. 2004 Aug;70(8):4831-9 [15294821.001]
  • [Cites] Nature. 2004 Dec 9;432(7018):750-3 [15592412.001]
  • (PMID = 16391045.001).
  • [ISSN] 0099-2240
  • [Journal-full-title] Applied and environmental microbiology
  • [ISO-abbreviation] Appl. Environ. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Carbon Radioisotopes; 0 / DNA, Bacterial; 0 / RNA, Ribosomal, 16S; 8SKN0B0MIM / Benzoic Acid
  • [Other-IDs] NLM/ PMC1352196
  •  go-up   go-down


38. Nouri K, Ballard CJ, Bouzari N, Saghari S: Basal cell carcinoma of the areola in a man. J Drugs Dermatol; 2005 May-Jun;4(3):352-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Basal cell carcinoma of the areola in a man.
  • Basal cell carcinomas (BCCs) that arise in sun-protected sites are quite uncommon.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Nipples / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15898292.001).
  • [ISSN] 1545-9616
  • [Journal-full-title] Journal of drugs in dermatology : JDD
  • [ISO-abbreviation] J Drugs Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


39. Boukamp P: Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis; 2005 Oct;26(10):1657-67
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Non-melanoma skin cancer: what drives tumor development and progression?
  • Non-melanoma skin cancer, i.e. basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most frequent tumors and their number is still increasing worldwide.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Carcinoma, Squamous Cell / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Disease Progression. Genes, myc. Genes, ras. Humans. Loss of Heterozygosity. Papillomaviridae / isolation & purification

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15905207.001).
  • [ISSN] 0143-3334
  • [Journal-full-title] Carcinogenesis
  • [ISO-abbreviation] Carcinogenesis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Number-of-references] 152
  •  go-up   go-down


40. Mostafa WZ, Mahfouz SM, Bosseila M, Sobhi RM, El-Nabarawy E: An immunohistochemical study of laminin in basal cell carcinoma. J Cutan Pathol; 2010 Jan;37(1):68-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An immunohistochemical study of laminin in basal cell carcinoma.
  • BACKGROUND: Laminins are components of the extracellular matrix that mediate cell adhesion, growth, migration, proliferation and differentiation.
  • Basement membrane (BM) laminins, in particular, may play a role in enhancing carcinoma cell motility.
  • AIM: To evaluate the distribution pattern of laminin in basal cell carcinoma (BCC), as regards the basement membrane, cellular cytoplasm, peritumoral lacunae and surface epithelium and to correlate laminin distribution with different variants of BCC.
  • Most laminin was in basement membrane zone (BMZ), and the more differentiated the tumor, the more cytoplasmic and BM staining it expressed.
  • [MeSH-major] Carcinoma, Basal Cell / metabolism. Laminin / metabolism. Skin Neoplasms / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Biomarkers, Tumor / metabolism. Biopsy. Child. Female. Humans. Immunohistochemistry / methods. Male. Middle Aged. Skin Aging. Young Adult

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2009 John Wiley & Sons A/S.
  • (PMID = 19615022.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Laminin
  •  go-up   go-down


41. Taneja S, Evans AJ, Rakha EA, Green AR, Ball G, Ellis IO: The mammographic correlations of a new immunohistochemical classification of invasive breast cancer. Clin Radiol; 2008 Nov;63(11):1228-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Twenty-five proteins of known relevance in breast cancer were assessed, including hormone receptors, HER-2 status, basal and luminal markers, p53 expression, and E-cadherin.
  • Groups characterized by HER-2 overexpression, basal characteristics, and E-cadherin positivity had a significantly higher proportion of ill-defined masses.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Breast Neoplasms / metabolism. Breast Neoplasms / radiography
  • [MeSH-minor] Adult. Aged. Cadherins / metabolism. Female. Humans. Lymphatic Metastasis. Mammography. Middle Aged. Neoplasm Invasiveness. Neoplasm Proteins / metabolism. Receptor, ErbB-2 / metabolism. Retrospective Studies. Tumor Suppressor Protein p53 / metabolism


42. Rollison DE, Giuliano AR, Sellers TA, Laronga C, Sweeney C, Risendal B, Baumgartner KB, Byers T, Slattery ML: Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol; 2008 Feb 15;167(4):447-56
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states.
  • Diabetes mellitus has been associated with breast cancer, although no studies appear to have adequately assessed the association in Hispanic women, a population with a high prevalence of diabetes.
  • The authors investigated this association in a population-based case-control study of Hispanic and non-Hispanic White women living in the southwestern United States.
  • Breast cancer cases diagnosed in 1999-2004 were identified through state cancer registries (1,526 non-Hispanic Whites, 798 Hispanics).
  • Age- and ethnicity-matched controls (1,599 non-Hispanic Whites, 924 Hispanics) were selected from commercial mailing lists and driver's license and Social Security records.
  • Diabetes history was assessed through interviewer-administered questionnaires.
  • Odds ratios and 95% confidence intervals were calculated using logistic regression, adjusting for age, body mass index at age 15 years, and parity.
  • Having any type of diabetes was not associated with breast cancer overall (odds ratio = 0.94, 95% confidence interval: 0.78, 1.12).
  • Type 2 diabetes was observed among 19% of Hispanics and 9% of non-Hispanic Whites but was not associated with breast cancer in either group.
  • Gestational diabetes was inversely associated with breast cancer in both ethnic groups, especially when first diagnosed at age < or =35 years (odds ratio = 0.54, 95% confidence interval: 0.37, 0.79).
  • In this study, diabetes was not associated with breast cancer overall, although the inverse association with gestational diabetes warrants further investigation.

  • Genetic Alliance. consumer health - Diabetes.
  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Diabetes.
  • MedlinePlus Health Information. consumer health - Hispanic American Health.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Diabetes Care. 2003 Apr;26(4):1047-51 [12663571.001]
  • [Cites] Breast Cancer Res Treat. 2008 Mar;108(1):129-35 [17476589.001]
  • [Cites] Int J Epidemiol. 1999 Oct;28(5):816-23 [10597976.001]
  • [Cites] J Natl Cancer Inst. 1970 Mar;44(3):673-86 [11515436.001]
  • [Cites] JAMA. 2002 Jan 16;287(3):356-9 [11790215.001]
  • [Cites] Cancer Causes Control. 2001 Dec;12(10):875-80 [11808705.001]
  • [Cites] Am J Epidemiol. 2002 Aug 15;156(4):349-52 [12181105.001]
  • [Cites] Cancer. 2004 Jan 1;100(1):149-55 [14692035.001]
  • [Cites] Cancer Causes Control. 2004 Apr;15(3):267-75 [15090721.001]
  • [Cites] Diabetes Care. 2004 May;27(5):1194-9 [15111544.001]
  • [Cites] Am J Epidemiol. 2004 Jun 15;159(12):1160-7 [15191933.001]
  • [Cites] Int J Cancer. 1974 Aug 15;14(2):153-60 [4378317.001]
  • [Cites] J Chronic Dis. 1982;35(1):13-9 [7068798.001]
  • [Cites] J Chronic Dis. 1985;38(5):435-41 [3998058.001]
  • [Cites] Diabetes Metab Rev. 1990 Feb;6(1):29-45 [2192854.001]
  • [Cites] Eur J Cancer. 1990;26(7):781-5 [2145895.001]
  • [Cites] Int J Gynaecol Obstet. 1991 May;35(1):13-8 [1680070.001]
  • [Cites] Diabetes Care. 1991 Jul;14(7):695-705 [1914821.001]
  • [Cites] Am J Epidemiol. 1992 May 1;135(9):965-73 [1595695.001]
  • [Cites] Epidemiology. 1994 Jan;5(1):102-8 [8117767.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1995 Dec;4(8):807-11 [8634649.001]
  • [Cites] Prev Med. 1997 Jan-Feb;26(1):144-53 [9010910.001]
  • [Cites] Int J Cancer. 1997 May 2;71(3):360-3 [9139868.001]
  • [Cites] Br J Cancer. 1997;75(11):1699-703 [9184190.001]
  • [Cites] J Natl Cancer Inst. 1997 Sep 17;89(18):1360-5 [9308706.001]
  • [Cites] Lancet. 1998 May 9;351(9113):1393-6 [9593409.001]
  • [Cites] Diabetes. 1998 Aug;47(8):1302-10 [9703332.001]
  • [Cites] Am J Epidemiol. 1998 Oct 1;148(7):683-92 [9778175.001]
  • [Cites] Epidemiology. 1998 Nov;9(6):641-7 [9799175.001]
  • [Cites] J Intern Med. 1997 Jun;241(6):471-5 [10497622.001]
  • [Cites] JAMA. 2005 Jan 12;293(2):194-202 [15644546.001]
  • [Cites] J Natl Cancer Inst. 2005 Mar 16;97(6):439-48 [15770008.001]
  • [Cites] Br J Cancer. 2005 Jun 6;92(11):2070-5 [15886700.001]
  • [Cites] Diabetes Care. 2006 Jun;29(6):1263-8 [16732006.001]
  • [Cites] Asian Pac J Cancer Prev. 2006 Apr-Jun;7(2):253-9 [16839219.001]
  • [Cites] Breast Cancer Res Treat. 2006 Aug;98(3):349-56 [16541321.001]
  • [Cites] Arch Intern Med. 2006 Sep 25;166(17):1871-7 [17000944.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):142-50 [17220343.001]
  • [Cites] Cancer Causes Control. 2007 Jun;18(5):505-15 [17437179.001]
  • [Cites] Int J Cancer. 2007 Aug 15;121(4):856-62 [17397032.001]
  • [Cites] Breast Cancer Res Treat. 2007 Mar;102(1):85-101 [17080310.001]
  • [Cites] Carcinogenesis. 2007 Jul;28(7):1561-6 [17440036.001]
  • [Cites] Breast Cancer Res Treat. 2007 Aug;104(2):197-209 [17051426.001]
  • [Cites] Diabetes Care. 2003 Jun;26(6):1752-8 [12766105.001]
  • (PMID = 18033764.001).
  • [ISSN] 1476-6256
  • [Journal-full-title] American journal of epidemiology
  • [ISO-abbreviation] Am. J. Epidemiol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA078682-07; United States / NCI NIH HHS / CA / CA078682; United States / NCI NIH HHS / CA / R01 CA078552; United States / NCI NIH HHS / CA / R01 CA078762; United States / NCI NIH HHS / CA / CA078682-07; United States / NCI NIH HHS / CA / R01 CA078802; United States / NCI NIH HHS / CA / R01 CA078682; United States / NCI NIH HHS / CA / CA078552; United States / NCI NIH HHS / PC / N01-PC-67000; United States / NCI NIH HHS / CA / CA078762; United States / NCI NIH HHS / CA / CA078802
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS50878; NLM/ PMC2925515
  •  go-up   go-down


43. Centers for Disease Control and Prevention (CDC): Decline in breast cancer incidence--United States, 1999-2003. MMWR Morb Mortal Wkly Rep; 2007 Jun 8;56(22):549-53
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / epidemiology

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17557070.001).
  • [ISSN] 1545-861X
  • [Journal-full-title] MMWR. Morbidity and mortality weekly report
  • [ISO-abbreviation] MMWR Morb. Mortal. Wkly. Rep.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


4
Advertisement
4. Sellers TA, Jensen LE, Vierkant RA, Fredericksen ZS, Brandt KR, Giuliano AR, Pankratz VS, Cerhan JR, Vachon CM: Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study. Cancer Causes Control; 2007 Jun;18(5):505-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / complications. Breast Neoplasms / epidemiology. Diabetes Mellitus, Type 2 / epidemiology. Mammography


45. Ishihara K, Saida T, Otsuka F, Yamazaki N, Prognosis and Statistical Investigation Committee of the Japanese Skin Cancer Society: Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol; 2008 Feb;13(1):33-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update.
  • BACKGROUND: In the previous report of the Prognosis and Statistical Investigation Committee of the Japanese Skin Cancer Society, we tabulated data on patients with malignant melanoma who had been registered at major medical institutions (22 institutions on average) in Japan over 5-year periods from 1987 to 1991 (group A) and from 1992 to 1996 (group B).
  • Because the International Union Against Cancer (UICC) TNM and stage classifications for malignant melanoma were changed substantially in 2002, analyses in the present investigation were performed according to the new classifications.
  • In addition, the numbers of patients with various kinds of skin malignancies, including not only malignant melanoma but also basal cell carcinoma, squamous cell carcinoma, mycosis fungoides, actinic keratosis, Bowen's disease, and Paget's disease, registered at approximately 100 medical institutions in Japan from 1987 to 2001, were also investigated and data were tabulated.
  • RESULTS: The nationwide survey of Japanese patients with malignant skin tumors from 1987 to 2001 showed that the most prevalent skin tumor was basal cell carcinoma, which increased year by year, followed by squamous cell carcinoma, and then by malignant melanoma.
  • For patients in stage III, the overall survival rate was higher in group C than that in group A or B, while there was no apparent difference in survival between the groups for patients in stage I or II.
  • For patients in stage IV, the survival rate in group C was slightly lower than that in group A or B. (7) In group C, the overall survival rates for substages III A, B, and C were ranked as III A > III B > III C. (8) The overall survival rates for stage IV M1a, M1b, and M1c were ranked as M1a > M1b > M1c.
  • CONCLUSION: In Japan, the number of patients with malignant skin tumors has increased year by year.
  • The prognosis of patients with advanced malignant melanoma remains extremely poor, but that of patients in stage III has shown an improvement.
  • [MeSH-major] Melanoma / epidemiology. Skin Neoplasms / epidemiology

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Epidemiol. 1995 Oct;24(5):897-907 [8557445.001]
  • [Cites] Int J Clin Oncol. 2003 Jun;8(3):139-50 [12851837.001]
  • [Cites] Int J Clin Oncol. 2001 Jun;6(3):109-16 [11706778.001]
  • [Cites] Cancer. 2000 Mar 15;88(6):1484-91 [10717634.001]
  • [Cites] J Clin Oncol. 2001 Aug 15;19(16):3635-48 [11504745.001]
  • [Cites] Harefuah. 1995 Jun 15;128(12):745-51, 824 [7557679.001]
  • (PMID = 18307017.001).
  • [ISSN] 1341-9625
  • [Journal-full-title] International journal of clinical oncology
  • [ISO-abbreviation] Int. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  •  go-up   go-down


46. Keller B, Braathen LR, Marti HP, Hunger RE: Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern. Swiss Med Wkly; 2010;140:w13036
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND/AIMS: Skin tumours, in particular squamous-cell carcinomas (SCC), are the most common malignant conditions developing in transplant recipients.
  • RESULTS: We found an increased risk of actinic keratosis (AK) and SCC in renal transplant recipients with a basal cell carcinoma (BCC) / SCC ratio of 1:7.
  • [MeSH-major] Carcinoma, Basal Cell / immunology. Carcinoma, Squamous Cell / immunology. Keratosis, Actinic / immunology. Kidney Transplantation / immunology. Postoperative Complications / immunology. Precancerous Conditions / immunology. Skin Neoplasms / immunology


47. Aulmann C, Seufert P, Sandherr M, Schlimok G, Schulze R, Oruzio D: [A 65-year-old female patient with breast cancer accompanied by thrombocytopenia and hyperfibrinolysis]. Internist (Berl); 2007 Sep;48(9):1015-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumor diseases can be accompanied by paraneoplastic syndromes.
  • A tumour disease with disturbed hemostasis caused by both plasmatic coagulation and thrombocytopenia has not yet been reported.
  • [MeSH-major] Breast Neoplasms / complications. Breast Neoplasms / diagnosis. Fibrinolysis. Hemorrhagic Disorders / complications. Hemorrhagic Disorders / diagnosis. Thrombocytopenia / complications. Thrombocytopenia / diagnosis

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Clin Oncol. 1999 Aug;22(4):411-3 [10440202.001]
  • [Cites] South Med J. 2002 Nov;95(11):1335-7 [12540004.001]
  • [Cites] Thromb Haemost. 2001 Sep;86(3):828-33 [11583315.001]
  • [Cites] Am J Clin Pathol. 1979 Jan;71(1):10-6 [420161.001]
  • [Cites] Am J Clin Oncol. 2000 Feb;23(1):74-7 [10683084.001]
  • [Cites] Respir Med. 2004 Feb;98(2):93-8 [14971870.001]
  • [Cites] Semin Thromb Hemost. 1996;22(6):459-78 [9122711.001]
  • [Cites] J Cancer Res Clin Oncol. 1997;123(10):555-9 [9393589.001]
  • [Cites] Jpn J Clin Oncol. 2001 Aug;31(8):388-94 [11574632.001]
  • [Cites] N Engl J Med. 1994 Nov 3;331(18):1207-11 [7935660.001]
  • [Cites] Blood Coagul Fibrinolysis. 2004 Jan;15(1):9-13 [15166937.001]
  • (PMID = 17704902.001).
  • [ISSN] 0020-9554
  • [Journal-full-title] Der Internist
  • [ISO-abbreviation] Internist (Berl)
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


48. Bendesky A, Rosales A, Salazar AM, Sordo M, Peniche J, Ostrosky-Wegman P: p53 codon 72 polymorphism, DNA damage and repair, and risk of non-melanoma skin cancer. Mutat Res; 2007 Jun 1;619(1-2):38-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It is not known, however, whether this polymorphism influences genome stability.
  • We analyzed whether p53 codon 72 genotype influences genomic stability and the sensitivity of cells to UVB.
  • There was no association between p53 genotype and basal levels of DNA damage, oxidative DNA damage sensitivity, or DNA repair capacity.
  • There was no significant association either between p53 genotype and basal cell carcinoma (BCC), squamous cell carcinoma (SCC) or both combined.
  • [MeSH-major] Carcinoma, Basal Cell / genetics. Carcinoma, Squamous Cell / genetics. DNA Damage / genetics. DNA Repair / genetics. Genes, p53. Polymorphism, Genetic. Skin Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17403527.001).
  • [ISSN] 0027-5107
  • [Journal-full-title] Mutation research
  • [ISO-abbreviation] Mutat. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Codon; 0 / DNA Primers
  •  go-up   go-down


49. Tsai KC, Chen YC, Hsiao NW, Wang CL, Lin CL, Lee YC, Li M, Wang B: A comparison of different electrostatic potentials on prediction accuracy in CoMFA and CoMSIA studies. Eur J Med Chem; 2010 Apr;45(4):1544-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A comparison of different electrostatic potentials on prediction accuracy in CoMFA and CoMSIA studies.
  • Computational chemistry is playing an increasingly important role in drug design and discovery, structural biology, and quantitative structure-activity relationship (QSAR) studies.
  • For QSAR work, selecting an appropriate and accurate method to assign the electrostatic potentials of each atom in a molecule is a critical first step.
  • So far several commonly used methods are available to assign charges.
  • However, no systematic comparison of the effects of electrostatic potentials on QSAR quality has been made.
  • In this study, twelve semi-empirical and empirical charge-assigning methods, AM1, AM1-BCC, CFF, Del-Re, Formal, Gasteiger, Gasteiger-Hückel, Hückel, MMFF, PRODRG, Pullman, and VC2003 charges, have been compared for their performances in CoMFA and CoMSIA modeling using several standard datasets.
  • Some charge assignment models, such as Del-Re, PRODRG, and Pullman, are limited to specific atom and bond types, and, therefore, were excluded from this study.
  • Among the remaining nine methods, the Gasteiger-Hückel charge, though commonly used, performed poorly in prediction accuracy.
  • The AM1-BCC method was better than most charge-assigning methods based on prediction accuracy, though it was not successful in yielding overall higher cross-validation correlation coefficient (q(2)) values than others.
  • The CFF charge model worked the best in prediction accuracy when q(2) was used as the evaluation criterion.
  • The results presented should help the selection of electrostatic potential models in CoMFA and CoMSIA studies.
  • [MeSH-major] Static Electricity
  • [MeSH-minor] Models, Molecular. Quantitative Structure-Activity Relationship

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.
  • (PMID = 20110138.001).
  • [ISSN] 1768-3254
  • [Journal-full-title] European journal of medicinal chemistry
  • [ISO-abbreviation] Eur J Med Chem
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] France
  •  go-up   go-down


50. Stanton BZ, Peng LF: Small-molecule modulators of the Sonic Hedgehog signaling pathway. Mol Biosyst; 2010 Jan;6(1):44-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Shh binds to its receptor, Patched (Ptch1), resulting in the de-repression of Smoothened (Smo).
  • Small-molecule modulators of Shh signaling provide a means to regulate the activity of a pathway implicated in medulloblastoma, basal cell carcinoma (BCC), pancreatic cancer, prostate cancer and developmental disorders.

  • Hazardous Substances Data Bank. CYCLOPAMINE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20024066.001).
  • [ISSN] 1742-2051
  • [Journal-full-title] Molecular bioSystems
  • [ISO-abbreviation] Mol Biosyst
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anilides; 0 / CUR 61414; 0 / Dioxoles; 0 / GANT58; 0 / Hedgehog Proteins; 0 / HhAntag691; 0 / IPI-926; 0 / Piperazines; 0 / Pyrazoles; 0 / Pyridines; 0 / Receptors, G-Protein-Coupled; 0 / SANT-1 compound; 0 / SMO protein, human; 0 / Thiophenes; 0 / Veratrum Alkaloids; ZH658AJ192 / cyclopamine
  • [Number-of-references] 89
  •  go-up   go-down


51. Peitsch WK, Hofmann I, Bulkescher J, Hergt M, Spring H, Bleyl U, Goerdt S, Franke WW: Drebrin, an actin-binding, cell-type characteristic protein: induction and localization in epithelial skin tumors and cultured keratinocytes. J Invest Dermatol; 2005 Oct;125(4):761-74
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Drebrin, an actin-binding, cell-type characteristic protein: induction and localization in epithelial skin tumors and cultured keratinocytes.
  • Isoform E2 of drebrin, an actin-binding protein originally identified in neuronal cells, has recently been identified in diverse non-neuronal cells, mostly in association with cell processes and intercellular junctions.
  • By immunohistochemistry and immunoblot, basal cell carcinomas (BCC) are rich in drebrin, and confocal laser scanning and immunoelectron microscopy show accumulation at adhering junctions, in co-localization with actin and partially with plaque proteins.
  • In squamous cell carcinomas, keratoacanthomas, and in epidermal precancers, drebrin is heterogeneously distributed, appearing as mosaics.
  • When epithelium-derived cells devoid of drebrin are transfected with drebrin-enhanced green fluorescent protein, constructs accumulate in the cell periphery, and immunoprecipitation shows complexes with actin.
  • During epidermal growth factor induced formation of cell processes, drebrin retains this junction association, as observed by live cell microscopy.
  • Our results suggest novel functions of drebrin such as an involvement in cell-cell adhesion and tumorigenesis and a potential value in diagnosis of BCC.
  • [MeSH-major] Keratinocytes / metabolism. Microfilament Proteins / analysis. Neoplasms, Glandular and Epithelial / chemistry. Neuropeptides / analysis. Skin Neoplasms / chemistry
  • [MeSH-minor] Cell Line, Tumor. Epidermal Growth Factor / pharmacology. Female. Fluorescent Antibody Technique. Humans. Immunoblotting. Microscopy, Confocal. Microscopy, Immunoelectron. Skin / chemistry. Transfection

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16185277.001).
  • [ISSN] 0022-202X
  • [Journal-full-title] The Journal of investigative dermatology
  • [ISO-abbreviation] J. Invest. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Microfilament Proteins; 0 / Neuropeptides; 0 / drebrin E; 62229-50-9 / Epidermal Growth Factor
  •  go-up   go-down


52. Turkovic L, Gurrin LC, Bahlo M, Dite GS, Southey MC, Hopper JL: Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age. BMC Cancer; 2010;10:466
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] BRCA1 Protein / genetics. BRCA2 Protein / genetics. Breast Neoplasms / genetics. Genetic Predisposition to Disease. Germ-Line Mutation / genetics. Haplotypes / genetics. Polymorphism, Genetic / genetics
  • [MeSH-minor] Adolescent. Adult. Australia. Case-Control Studies. Female. Founder Effect. Humans. Middle Aged. Neoplasm Staging. Prognosis. Risk Factors. Survival Rate. Young Adult

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Genome Res. 2001 Jan;11(1):143-51 [11156623.001]
  • [Cites] Breast Cancer Res Treat. 2009 Jul;116(2):379-86 [18704680.001]
  • [Cites] Am J Hum Genet. 2002 Feb;70(2):425-34 [11791212.001]
  • [Cites] Hum Mutat. 2002 Jul;20(1):65-73 [12112659.001]
  • [Cites] J Natl Cancer Inst. 2003 Mar 19;95(6):448-57 [12644538.001]
  • [Cites] Eur J Hum Genet. 2003 Jun;11(6):489-92 [12774043.001]
  • [Cites] Am J Hum Genet. 2003 Nov;73(5):1162-9 [14574645.001]
  • [Cites] Am J Hum Genet. 2004 Jan;74(1):106-20 [14681826.001]
  • [Cites] Am J Hum Genet. 2004 Jul;75(1):35-43 [15148658.001]
  • [Cites] Hum Mol Genet. 2004 Oct 15;13(20):2431-41 [15317758.001]
  • [Cites] Hum Mol Genet. 1997 Feb;6(2):285-9 [9063749.001]
  • [Cites] J Natl Cancer Inst. 1998 Apr 1;90(7):532-6 [9539249.001]
  • [Cites] Bioinformatics. 2005 Jan 15;21(2):263-5 [15297300.001]
  • [Cites] Breast Cancer Res. 2005;7(2):R171-5 [15743496.001]
  • [Cites] Cancer Res. 2005 Aug 15;65(16):7516-22 [16103107.001]
  • [Cites] Am J Hum Genet. 2001 Apr;68(4):978-89 [11254454.001]
  • (PMID = 20807450.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / BRCA1 Protein; 0 / BRCA1 protein, human; 0 / BRCA2 Protein; 0 / BRCA2 protein, human
  • [Other-IDs] NLM/ PMC2940805
  •  go-up   go-down


53. Silva Idos S, De Stavola B, McCormack V, Collaborative Group on Pre-Natal Risk Factors and Subsequent Risk of Breast Cancer: Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies. PLoS Med; 2008 Sep 30;5(9):e193
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies.
  • BACKGROUND: Birth size, perhaps a proxy for prenatal environment, might be a correlate of subsequent breast cancer risk, but findings from epidemiological studies have been inconsistent.
  • We re-analysed individual participant data from published and unpublished studies to obtain more precise estimates of the magnitude and shape of the birth size-breast cancer association.
  • METHODS AND FINDINGS: Studies were identified through computer-assisted and manual searches, and personal communication with investigators.
  • Individual participant data from 32 studies, comprising 22,058 breast cancer cases, were obtained.
  • Random effect models were used, if appropriate, to combine study-specific estimates of effect.
  • Birth weight was positively associated with breast cancer risk in studies based on birth records (pooled relative risk [RR] per one standard deviation [SD] [= 0.5 kg] increment in birth weight: 1.06; 95% confidence interval [CI] 1.02-1.09) and parental recall when the participants were children (1.02; 95% CI 0.99-1.05), but not in those based on adult self-reports, or maternal recall during the woman's adulthood (0.98; 95% CI 0.95-1.01) (p for heterogeneity between data sources = 0.003).
  • Relative to women who weighed 3.000-3.499 kg, the risk was 0.96 (CI 0.80-1.16) in those who weighed < 2.500 kg, and 1.12 (95% CI 1.00-1.25) in those who weighed > or = 4.000 kg (p for linear trend = 0.001) in birth record data.
  • Birth length and head circumference from birth records were also positively associated with breast cancer risk (pooled RR per one SD increment: 1.06 [95% CI 1.03-1.10] and 1.09 [95% CI 1.03-1.15], respectively).
  • Simultaneous adjustment for these three birth size variables showed that length was the strongest independent predictor of risk.
  • The birth size effects did not appear to be confounded or mediated by established breast cancer risk factors and were not modified by age or menopausal status.
  • The cumulative incidence of breast cancer per 100 women by age 80 y in the study populations was estimated to be 10.0, 10.0, 10.4, and 11.5 in those who were, respectively, in the bottom, second, third, and top fourths of the birth length distribution.
  • CONCLUSIONS: This pooled analysis of individual participant data is consistent with birth size, and in particular birth length, being an independent correlate of breast cancer risk in adulthood.

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Birth Weight.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Cancer. 2003 Nov 3;89(9):1664-6 [14583767.001]
  • [Cites] Int J Cancer. 2003 Dec 20;107(6):997-1000 [14601061.001]
  • [Cites] Br J Cancer. 2004 Nov 1;91(9):1666-8 [15477861.001]
  • [Cites] Br J Cancer. 1988 Apr;57(4):437-9 [3390382.001]
  • [Cites] Lancet. 1990 Apr 21;335(8695):939-40 [1970028.001]
  • [Cites] Lancet. 1992 Oct 24;340(8826):1015-8 [1357410.001]
  • [Cites] Biometrics. 1992 Sep;48(3):795-806 [1420842.001]
  • [Cites] Epidemiology. 1996 Jan;7(1):34-7 [8664398.001]
  • [Cites] Lancet. 1996 Dec 7;348(9041):1542-6 [8950880.001]
  • [Cites] J Natl Cancer Inst. 1997 Jan 1;89(1):71-6 [8978409.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1997 May;24(5):497-505 [9161941.001]
  • [Cites] J Clin Endocrinol Metab. 1997 Oct;82(10):3281-4 [9329354.001]
  • [Cites] Paediatr Perinat Epidemiol. 1998 Oct;12(4):397-407 [9805713.001]
  • [Cites] J Clin Endocrinol Metab. 1999 Mar;84(3):1145-8 [10084609.001]
  • [Cites] Am J Epidemiol. 1999 Apr 15;149(8):726-9 [10206622.001]
  • [Cites] Cancer Causes Control. 1999 Feb;10(1):85-94 [10334647.001]
  • [Cites] Pediatr Nurs. 1999 Jan-Feb;25(1):13-7 [10335245.001]
  • [Cites] Breast Cancer Res. 2004;6(6):R656-67 [15535848.001]
  • [Cites] Int J Cancer. 2005 Apr 10;114(3):461-4 [15551343.001]
  • [Cites] Int J Cancer. 2005 Jul 1;115(4):611-7 [15700315.001]
  • [Cites] Diabetologia. 2005 Sep;48(9):1736-42 [16052327.001]
  • [Cites] Cancer Causes Control. 2006 May;17(4):395-401 [16596291.001]
  • [Cites] Am J Epidemiol. 2006 Jun 1;163(11):1053-64 [16624970.001]
  • [Cites] Br J Cancer. 2006 Jun 5;94(11):1734-7 [16641898.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1469-72 [16896034.001]
  • [Cites] Obesity (Silver Spring). 2006 Jul;14(7):1257-63 [16899807.001]
  • [Cites] Int J Cancer. 2006 Nov 1;119(9):2136-41 [16804898.001]
  • [Cites] Int J Cancer. 2006 Nov 1;119(9):2007-25 [16823839.001]
  • [Cites] Trends Endocrinol Metab. 2006 Nov;17(9):340-8 [16997567.001]
  • [Cites] Carcinogenesis. 2006 Dec;27(12):2464-8 [16777984.001]
  • [Cites] Breast Cancer Res. 2007;9(3):R29 [17501995.001]
  • [Cites] Int J Cancer. 2008 Feb 1;122(3):481-5 [18022897.001]
  • [Cites] Lancet Oncol. 2007 Dec;8(12):1088-100 [18054879.001]
  • [Cites] Epidemiology. 2008 Mar;19(2):197-203 [18300695.001]
  • [Cites] Breast Cancer Res. 2008;10(1):R8 [18205956.001]
  • [Cites] Pediatr Res. 1999 Nov;46(5):491-5 [10541308.001]
  • [Cites] Epidemiology. 2000 May;11(3):315-9 [10784250.001]
  • [Cites] J Natl Cancer Inst. 2000 May 17;92(10):840-1 [10814680.001]
  • [Cites] Br J Cancer. 2000 Oct;83(7):964-8 [10970703.001]
  • [Cites] Am J Epidemiol. 2000 Sep 15;152(6):514-27 [10997541.001]
  • [Cites] J Natl Cancer Inst. 2001 Jan 3;93(1):60-2 [11136844.001]
  • [Cites] Int J Cancer. 2001 Jan 15;91(2):248-51 [11146453.001]
  • [Cites] Am J Epidemiol. 2000 Dec 15;152(12):1121-8 [11130617.001]
  • [Cites] Br J Cancer. 2001 May 4;84(9):1193-8 [11336470.001]
  • [Cites] Stat Med. 2001 Jul 30;20(14):2115-30 [11439425.001]
  • [Cites] Acta Obstet Gynecol Scand. 2001 Oct;80(10):931-6 [11580738.001]
  • [Cites] Br J Cancer. 2001 Nov 30;85(11):1680-4 [11742488.001]
  • [Cites] Br J Cancer. 2002 Jan 7;86(1):84-8 [11857016.001]
  • [Cites] Br J Cancer. 2002 Jan 7;86(1):89-91 [11857017.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2002 Feb;11(2):207-10 [11867509.001]
  • [Cites] Pediatrics. 2002 Jun;109(6):1131-5 [12042554.001]
  • [Cites] Semin Perinatol. 2002 Aug;26(4):260-7 [12211616.001]
  • [Cites] Br J Cancer. 2002 Nov 18;87(11):1234-45 [12439712.001]
  • [Cites] Am J Epidemiol. 2003 Feb 1;157(3):258-66 [12543626.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Dec;88(12):5656-60 [14671149.001]
  • [Cites] Br J Cancer. 2004 Aug 2;91(3):519-24 [15266328.001]
  • [Cites] Obstet Gynecol. 2004 Oct;104(4):671-7 [15458884.001]
  • [Cites] Obstet Gynecol. 2004 Oct;104(4):720-6 [15458892.001]
  • [Cites] N Engl J Med. 2004 Oct 14;351(16):1619-26 [15483280.001]
  • [Cites] BMJ. 2003 Feb 1;326(7383):248 [12560272.001]
  • [Cites] Breast Cancer Res. 2003;5(1):42-4 [12559045.001]
  • [Cites] Cancer Causes Control. 2003 Feb;14(1):61-4 [12708726.001]
  • [Cites] Cancer Causes Control. 2003 May;14(4):347-55 [12846366.001]
  • [Cites] BMJ. 2003 Sep 6;327(7414):557-60 [12958120.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):860-5 [14504195.001]
  • [CommentIn] PLoS Med. 2008 Sep 30;5(9):e194 [18828668.001]
  • (PMID = 18828667.001).
  • [ISSN] 1549-1676
  • [Journal-full-title] PLoS medicine
  • [ISO-abbreviation] PLoS Med.
  • [Language] ENG
  • [Grant] United Kingdom / Cancer Research UK / / C14292/A5609; United Kingdom / Cancer Research UK / / C150/A5660
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2553821
  •  go-up   go-down


54. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE: Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst; 2006 Oct 4;98(19):1406-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / epidemiology. Breast Neoplasms / metabolism. Gonadal Steroid Hormones / blood. Premenopause

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. ESTRADIOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Natl Cancer Inst. 2007 Mar 7;99(5):408-9; author reply 409-10 [17341734.001]
  • (PMID = 17018787.001).
  • [ISSN] 1460-2105
  • [Journal-full-title] Journal of the National Cancer Institute
  • [ISO-abbreviation] J. Natl. Cancer Inst.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA50385; United States / NCI NIH HHS / CA / CA67262; United States / NCI NIH HHS / CA / R25 CA098566-02; United States / NCI NIH HHS / CA / T32 CA090001-281
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Androgens; 0 / Estrogens; 0 / Gonadal Steroid Hormones; 0 / Sex Hormone-Binding Globulin; 4TI98Z838E / Estradiol
  •  go-up   go-down


55. Dong X, Reddy GB: Soil bacterial communities in constructed wetlands treated with swine wastewater using PCR-DGGE technique. Bioresour Technol; 2010 Feb;101(4):1175-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Soil bacterial communities in constructed wetlands treated with swine wastewater using PCR-DGGE technique.
  • Marsh-pond-marsh (MPM) constructed wetlands were designed for the treatment of swine wastewater.
  • The goal of this study was to characterize bacterial communities in these wetlands and determine the nutrient removal from influent to effluent.
  • Surface soil samples were collected and analyzed by culture-dependent and culture-independent techniques.
  • The results showed that the bacterial colony forming units (CFU) and the average concentrations of total nitrogen, NH(4)(+), total phosphorous (TP) and PO(4)(3-) from the influent to the effluent decreased.
  • The NH(4)(+) and the PO(4)(3-) concentrations showed the most dramatic changes, with decreases of 39.97% and 16.92%, respectively.
  • Data of culture-independent samples produced by using PCR-denaturing gradient gel electrophoresis (DGGE) technique showed that the Shannon diversity index and richness decreased significantly (P<0.05) from influent to effluent.
  • Bacterium species distributions strongly correlated with the concentrations of TP, NH(4)(+) and the PO(4)(3-).
  • Sequencing of partial 16S rRNA genes fragments revealed that the total bacterial community composition was dominated by Pseudomonas sp., Arthrobacter sp., Bacillus sp. and other soil bacteria.
  • Anammox (anaerobic ammonium oxidation) stains were detected.
  • Phylogenetic analysis demonstrated that some of the partial 16S rRNA gene sequences had close relationships with unculturable denitrification bacteria.
  • The activities of these bacteria might contribute to the nutrient removal in the wetlands.
  • [MeSH-major] Bacteria / growth & development. Electrophoresis, Agar Gel / methods. Polymerase Chain Reaction / methods. Soil Microbiology. Sus scrofa. Waste Disposal, Fluid. Wetlands
  • [MeSH-minor] Animals. Biodiversity. Cluster Analysis. Colony Count, Microbial. Environment. Nucleic Acid Denaturation. Phylogeny. Principal Component Analysis. RNA, Ribosomal, 16S / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19822421.001).
  • [ISSN] 1873-2976
  • [Journal-full-title] Bioresource technology
  • [ISO-abbreviation] Bioresour. Technol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Ribosomal, 16S
  •  go-up   go-down


56. Scheithauer BK, Wos-Oxley ML, Ferslev B, Jablonowski H, Pieper DH: Characterization of the complex bacterial communities colonizing biliary stents reveals a host-dependent diversity. ISME J; 2009 Jul;3(7):797-807
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characterization of the complex bacterial communities colonizing biliary stents reveals a host-dependent diversity.
  • This study provides a comprehensive survey of the spatial and temporal bacterial composition of biliary stent biofilms.
  • The bacterial diversity, distribution and dynamics of 59 biliary and 4 pancreatic stent communities from 40 patients being treated at two different hospitals, which implant stents either simultaneously or consecutively, were characterized by single-strand conformation polymorphism (SSCP) analysis.
  • Fifty-one phylotypes belonging to 5 bacterial phyla and 24 bacterial families were detected across 63 stents.
  • This is a much broader diversity than previously detected through culture-dependent methods, particularly in regard to the diversity of obligate anaerobes.
  • Stent bacterial diversity was patient-dependent and more similar when stents were implanted simultaneously rather than consecutively.
  • Stent bacterial community composition differed between hospitals specifically because of the difference in abundance of Bifidobacteria.
  • Co-colonization of Veillonella sp., Streptococcus anginosus and organisms closely related to Fusobacterium nucleatum revealed a potentially important attachment and survival strategy that has yet to be reported in biliary stents.
  • This work reveals a more complete survey of the identities of bacterial species that form biofilms in biliary stents, their co-colonization patterns and the natural variation in species composition between different patients, hospitals and locations along the stent.
  • Consideration of the community composition from individual patients will allow tailoring of prophylactic antibiotic treatments and thus will make the management of stent biofilms more effective.
  • [MeSH-major] Bacteria / classification. Bacteria / isolation & purification. Biodiversity. Common Bile Duct / microbiology. Stents / microbiology
  • [MeSH-minor] Cluster Analysis. DNA, Ribosomal / genetics. Humans. Molecular Sequence Data. Phylogeny. Polymorphism, Single-Stranded Conformational. RNA, Ribosomal, 16S / genetics. Sequence Analysis, DNA

  • SILVA. SILVA SSU Database .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19360025.001).
  • [ISSN] 1751-7370
  • [Journal-full-title] The ISME journal
  • [ISO-abbreviation] ISME J
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ EU704129/ EU704130/ EU704131/ EU704132/ EU704133/ EU704134/ EU704135/ EU704136/ EU704137/ EU704138/ EU704139/ EU704140/ EU704141/ EU704142/ EU704143/ EU704144/ EU704145/ EU704146/ EU704147/ EU704148/ EU704149/ EU704150/ EU704151/ EU704152/ EU704153/ EU704154/ EU704155/ EU704156/ EU704157/ EU704158/ EU704159/ EU704160/ EU704161/ EU704162/ EU704163/ EU704164/ EU704165/ EU704166/ EU704167/ EU704168/ EU704169/ EU704170/ EU704171/ EU704172/ EU704173/ EU704174/ EU704175/ EU704176/ EU704177/ EU704178/ EU704179/ EU704180/ EU704181/ EU704182/ EU704183/ EU704184/ EU704185/ EU704186/ EU704187/ EU704188/ EU704189/ EU704190/ EU704191/ EU704192/ EU704193/ EU704194/ EU704195/ EU704196/ EU704197/ EU704198/ EU704199/ EU704200/ EU704201/ EU704202/ EU704203/ EU704204/ EU704205/ EU704206/ EU704207/ EU704208/ EU704209/ EU704210/ EU704211/ EU704212/ EU704213/ EU704214/ EU704215/ EU704216/ EU704217/ EU704218/ EU704219/ EU704220/ EU704221/ EU704222/ EU704223/ EU704224/ EU704225/ EU704226/ EU704227/ EU704228/ EU704229/ EU704230/ EU704231/ EU704232/ EU704233/ EU704234/ EU704235/ EU704236/ EU704237/ EU704238/ EU704239/ EU704240/ EU704241/ EU704242/ EU704243/ EU704244/ EU704245/ EU704246/ EU704247/ EU704248/ EU704249/ EU704250/ EU915501/ EU915502/ EU915503/ EU915504
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Ribosomal; 0 / RNA, Ribosomal, 16S
  •  go-up   go-down


57. Wang Z, Xu Y, Tang J, Ma H, Qin J, Lu C, Wang X, Hu Z, Wang X, Shen H: A polymorphism in Werner syndrome gene is associated with breast cancer susceptibility in Chinese women. Breast Cancer Res Treat; 2009 Nov;118(1):169-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / genetics. Exodeoxyribonucleases / genetics. Genes, Neoplasm. Menarche / genetics. Neoplasm Proteins / genetics. Polymorphism, Single Nucleotide. RecQ Helicases / genetics. Werner Syndrome / genetics
  • [MeSH-minor] Adult. Aged. Amino Acid Substitution. Case-Control Studies. China / epidemiology. Female. Genes, BRCA1. Genetic Predisposition to Disease. Genotype. Humans. Menopause. Middle Aged. Receptors, Estrogen / analysis. Receptors, Progesterone / analysis. Risk

  • Genetic Alliance. consumer health - Werner's syndrome.
  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19205873.001).
  • [ISSN] 1573-7217
  • [Journal-full-title] Breast cancer research and treatment
  • [ISO-abbreviation] Breast Cancer Res. Treat.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Neoplasm Proteins; 0 / Receptors, Estrogen; 0 / Receptors, Progesterone; EC 3.1.- / Exodeoxyribonucleases; EC 3.6.1.- / Bloom syndrome protein; EC 3.6.1.- / WRN protein, human; EC 3.6.4.12 / RecQ Helicases
  •  go-up   go-down


58. Kuo WH, Yen AM, Lee PH, Chen KM, Wang J, Chang KJ, Chen TH, Tsau HS: Cumulative survival in early-onset unilateral and bilateral breast cancer: an analysis of 1907 Taiwanese women. Br J Cancer; 2009 Feb 24;100(4):563-70
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Time-dependent Cox regression was used to assess the risk of breast cancer death by considering the time course of unilateral and bilateral tumour development.
  • [MeSH-major] Breast Neoplasms / mortality. Breast Neoplasms / pathology

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 2000 May 27;355(9218):1869-74 [10866443.001]
  • [Cites] Eur J Cancer. 2008 Dec;44(18):2774-80 [19027287.001]
  • [Cites] World J Surg. 2001 Sep;25(9):1117-24 [11571945.001]
  • [Cites] Int J Cancer. 2004 Mar 1;108(6):901-6 [14712495.001]
  • [Cites] Arch Surg. 2004 Jan;139(1):27-30; discussion 31 [14718270.001]
  • [Cites] Cancer. 1984 Dec 15;54(12):3002-11 [6498774.001]
  • [Cites] Aust N Z J Surg. 1989 Jan;59(1):35-7 [2913992.001]
  • [Cites] J Natl Cancer Inst. 1993 Nov 17;85(22):1819-27 [8230262.001]
  • [Cites] Cancer. 1993 Dec 15;72(12):3629-35 [8252478.001]
  • [Cites] Am J Epidemiol. 1995 Dec 15;142(12):1255-64 [7503045.001]
  • [Cites] N Engl J Med. 1996 Jan 18;334(3):143-9 [8531968.001]
  • [Cites] Int J Epidemiol. 1996 Feb;25(1):40-5 [8666502.001]
  • [Cites] Am J Clin Oncol. 1997 Dec;20(6):541-5 [9391536.001]
  • [Cites] Int J Oncol. 1999 Jun;14(6):1103-9 [10339665.001]
  • [Cites] Fam Cancer. 2004;3(3-4):249-57 [15516849.001]
  • [Cites] Int J Cancer. 2005 Jan 10;113(2):302-6 [15386413.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):243-50 [15668501.001]
  • [Cites] Lancet. 2005 May 14-20;365(9472):1687-717 [15894097.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1986-90 [16103449.001]
  • [Cites] Lancet. 2005 Dec 17;366(9503):2087-106 [16360786.001]
  • [Cites] Breast Cancer Res Treat. 2006 Sep;99(2):221-8 [16544057.001]
  • [Cites] BMC Cancer. 2006;6:261 [17078893.001]
  • [Cites] J Clin Oncol. 2007 Jun 10;25(17):2360-8 [17515570.001]
  • [Cites] Int J Cancer. 2007 Sep 1;121(5):1017-20 [17471561.001]
  • [Cites] N Engl J Med. 2007 Jul 12;357(2):115-23 [17625123.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1437-42 [17627009.001]
  • [Cites] J Clin Oncol. 2007 Sep 20;25(27):4210-6 [17878475.001]
  • [Cites] J Clin Oncol. 2008 Jul 10;26(20):3324-30 [18612148.001]
  • [Cites] Cancer Detect Prev. 2008;32(2):156-61 [18632223.001]
  • [Cites] Cancer. 2001 May 15;91(10):1845-53 [11346865.001]
  • (PMID = 19190627.001).
  • [ISSN] 1532-1827
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2653740
  •  go-up   go-down


59. Melchor L, Honrado E, Huang J, Alvarez S, Naylor TL, García MJ, Osorio A, Blesa D, Stratton MR, Weber BL, Cigudosa JC, Rahman N, Nathanson KL, Benítez J: Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer. Clin Cancer Res; 2007 Dec 15;13(24):7305-13
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We found that the presence/absence of the estrogen receptor (ER) may play a crucial role in driving tumor development through distinct genomic pathways independently of the tumor type (sporadic or familial) and mutation status (BRCA1 or BRCA2).
  • [MeSH-major] Breast Neoplasms / genetics. Breast Neoplasms / metabolism. Genes, BRCA1. Genes, BRCA2. Genomic Instability. Receptors, Estrogen / metabolism
  • [MeSH-minor] Chromosomes, Artificial, Bacterial. Female. Genetic Predisposition to Disease. Humans. Mutation. Nucleic Acid Hybridization


60. Homaei-Shandiz F, Ghavam-Nassiri MR, Sharifi N, Homaei-Shandiz AH, Taghizadeh-Kermani A, Torshizi SA, Ghafarzadegan K: Evaluation of the relationship between human epidermal growth factor receptor-2/neu (c-erbB-2) amplification and pathologic grading in patients with breast cancer. Saudi Med J; 2006 Dec;27(12):1810-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / genetics. Breast Neoplasms / pathology. Gene Amplification. Gene Expression Regulation, Neoplastic / genetics. Receptor, ErbB-2 / genetics


61. Yazici AC, Unal S, Ikizoglu G, Kokturk A, Baz K, Cinel L, Koca A: Superficial basal cell carcinoma of the scalp mimicking seborrhoeic dermatitis. Scand J Plast Reconstr Surg Hand Surg; 2006;40(1):54-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Superficial basal cell carcinoma of the scalp mimicking seborrhoeic dermatitis.
  • Superficial basal cell carcinomas (BCC) comprise 9% to 11% of BCC, and are commonly found on the trunk or limbs.

  • MedlinePlus Health Information. consumer health - Dandruff, Cradle Cap, and Other Scalp Conditions.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16428215.001).
  • [ISSN] 0284-4311
  • [Journal-full-title] Scandinavian journal of plastic and reconstructive surgery and hand surgery
  • [ISO-abbreviation] Scand J Plast Reconstr Surg Hand Surg
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


62. Lynch KH, Seed KD, Stothard P, Dennis JJ: Inactivation of Burkholderia cepacia complex phage KS9 gp41 identifies the phage repressor and generates lytic virions. J Virol; 2010 Feb;84(3):1276-88
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Burkholderia cepacia complex (BCC) is made up of at least 17 species of gram-negative opportunistic bacterial pathogens that cause fatal infections in patients with cystic fibrosis and chronic granulomatous disease.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Microbiol. 2003 Jul;49(2):277-300 [12886937.001]
  • [Cites] Protein Sci. 2003 Aug;12(8):1652-62 [12876315.001]
  • [Cites] J Mol Biol. 2004 Jun 25;340(1):49-65 [15184022.001]
  • [Cites] Mol Cell. 2004 Oct 8;16(1):11-21 [15469818.001]
  • [Cites] J Clin Microbiol. 1975 May;1(5):425-8 [1176612.001]
  • [Cites] J Bacteriol. 1976 Oct;128(1):242-7 [135755.001]
  • [Cites] Microbiol Rev. 1978 Jun;42(2):385-413 [353481.001]
  • [Cites] J Pediatr. 1984 Feb;104(2):206-10 [6420530.001]
  • [Cites] Appl Environ Microbiol. 1990 May;56(5):1279-85 [2339883.001]
  • [Cites] Lancet. 1993 Jul 3;342(8862):15-9 [7686239.001]
  • [Cites] Nucleic Acids Res. 1997 Sep 1;25(17):3389-402 [9254694.001]
  • [Cites] Nucleic Acids Res. 1998 Feb 15;26(4):1107-15 [9461475.001]
  • [Cites] Appl Environ Microbiol. 1998 Jul;64(7):2710-5 [9647854.001]
  • [Cites] Biotechniques. 1998 Nov;25(5):772-4, 776 [9821576.001]
  • [Cites] Curr Opin Genet Dev. 2004 Dec;14(6):609-15 [15531154.001]
  • [Cites] Bioinformatics. 2005 Aug 15;21(16):3422-3 [15976072.001]
  • [Cites] FEMS Microbiol Lett. 2005 Oct 15;251(2):273-80 [16140471.001]
  • [Cites] J Biol Chem. 2005 Nov 4;280(44):36912-9 [16115872.001]
  • [Cites] J Bacteriol. 2006 Mar;188(6):2073-80 [16513737.001]
  • [Cites] Int J Antimicrob Agents. 2007 Aug;30(2):118-28 [17566713.001]
  • [Cites] Curr Opin Microbiol. 2007 Aug;10(4):410-7 [17719265.001]
  • [Cites] Infect Immun. 2008 Mar;76(3):1267-75 [18195031.001]
  • [Cites] Bioinformatics. 2008 Aug 1;24(15):1662-8 [18474507.001]
  • [Cites] Mol Microbiol. 2008 Oct;70(2):341-51 [18713319.001]
  • [Cites] Antimicrob Agents Chemother. 2009 May;53(5):2205-8 [19223640.001]
  • [Cites] J Biol Chem. 2009 Aug 7;284(32):21738-51 [19525227.001]
  • [Cites] J Clin Microbiol. 2000 Feb;38(2):910-3 [10655415.001]
  • [Cites] Trends Microbiol. 2000 Mar;8(3):120-8 [10707065.001]
  • [Cites] J Theor Biol. 2001 Jan 7;208(1):37-48 [11162051.001]
  • [Cites] Appl Environ Microbiol. 2001 Jun;67(6):2790-8 [11375196.001]
  • [Cites] Arch Virol. 2001;146(5):843-57 [11448025.001]
  • [Cites] Infect Immun. 2002 Jan;70(1):204-10 [11748184.001]
  • [Cites] Emerg Infect Dis. 2002 Feb;8(2):181-7 [11897071.001]
  • [Cites] J Bacteriol. 2002 Jul;184(14):4003-17 [12081973.001]
  • [Cites] Thorax. 2002 Sep;57(9):756-8 [12200517.001]
  • [Cites] Trends Microbiol. 2002 Nov;10(11):521-9 [12419617.001]
  • [Cites] Microbiol Mol Biol Rev. 2003 Mar;67(1):86-156, table of contents [12626685.001]
  • [Cites] Nat Rev Drug Discov. 2003 Jun;2(6):489-97 [12776223.001]
  • [Cites] J Clin Microbiol. 2003 Jun;41(6):2797-8 [12791937.001]
  • [Cites] Nucleic Acids Res. 2003 Jul 1;31(13):3406-15 [12824337.001]
  • [Cites] FEMS Microbiol Lett. 2003 Jun 27;223(2):259-65 [12829296.001]
  • [Cites] J Bacteriol. 2004 Jun;186(12):3938-50 [15175308.001]
  • (PMID = 19939932.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] Canada / Canadian Institutes of Health Research / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA Primers; 0 / Repressor Proteins
  • [Other-IDs] NLM/ PMC2812329
  •  go-up   go-down


63. Laird BB, Davidchack RL: Direct calculation of the crystal-melt interfacial free energy via molecular dynamics computer simulation. J Phys Chem B; 2005 Sep 29;109(38):17802-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The calculation is sufficiently precise to resolve the small anisotropy in gamma, which is crucial in determining the kinetics and morphology of dendritic growth.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16853283.001).
  • [ISSN] 1520-6106
  • [Journal-full-title] The journal of physical chemistry. B
  • [ISO-abbreviation] J Phys Chem B
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


64. Rudolph J, Berl J, Hamm B, Klingebiel R: Magnetic resonance imaging findings of basal cell adenoma in Curschmann-Steinert myotonic dystrophy. Acta Radiol; 2006 Mar;47(2):205-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Magnetic resonance imaging findings of basal cell adenoma in Curschmann-Steinert myotonic dystrophy.
  • We present the magnetic resonance imaging in the unusual combination of a patient with known myotonic dystrophy and recurrent basal cell tumor.
  • [MeSH-major] Adenoma / diagnosis. Carcinoma, Basal Cell / diagnosis. Head and Neck Neoplasms / diagnosis. Magnetic Resonance Imaging. Myotonic Dystrophy / pathology

  • Genetic Alliance. consumer health - Myotonic dystrophy.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16604969.001).
  • [ISSN] 0284-1851
  • [Journal-full-title] Acta radiologica (Stockholm, Sweden : 1987)
  • [ISO-abbreviation] Acta Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Sweden
  •  go-up   go-down


65. Riemann L, Leitet C, Pommier T, Simu K, Holmfeldt K, Larsson U, Hagström A: The native bacterioplankton community in the central baltic sea is influenced by freshwater bacterial species. Appl Environ Microbiol; 2008 Jan;74(2):503-15
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The native bacterioplankton community in the central baltic sea is influenced by freshwater bacterial species.
  • The Baltic Sea is one of the largest brackish environments on Earth.
  • Despite extensive knowledge about food web interactions and pelagic ecosystem functioning, information about the bacterial community composition in the Baltic Sea is scarce.
  • We hypothesized that due to the eutrophic low-salinity environment and the long water residence time (>5 years), the bacterioplankton community from the Baltic proper shows a native "brackish" composition influenced by both freshwater and marine phylotypes.
  • The bacterial community composition in surface water (3-m depth) was examined at a single station throughout a full year.
  • Denaturing gradient gel electrophoresis (DGGE) showed that the community composition changed over the year.
  • Further, it indicated that at the four extensive samplings (16S rRNA gene clone libraries and bacterial isolates from low- and high-nutrient agar plates and seawater cultures), different bacterial assemblages associated with different environmental conditions were present.
  • Overall, the sequencing of 26 DGGE bands, 160 clones, 209 plate isolates, and 9 dilution culture isolates showed that the bacterial assemblage in surface waters of the central Baltic Sea was dominated by Bacteroidetes but exhibited a pronounced influence of typical freshwater phylogenetic groups within Actinobacteria, Verrucomicrobia, and Betaproteobacteria and a lack of typical marine taxa.
  • This first comprehensive analysis of bacterial community composition in the central Baltic Sea points to the existence of an autochthonous estuarine community uniquely adapted to the environmental conditions prevailing in this brackish environment.
  • [MeSH-major] Bacteria / growth & development. Fresh Water / microbiology. Plankton / growth & development. Seawater / microbiology
  • [MeSH-minor] Actinobacteria / classification. Actinobacteria / genetics. Actinobacteria / growth & development. Animals. Bacteroidetes / classification. Bacteroidetes / genetics. Bacteroidetes / growth & development. Betaproteobacteria / classification. Betaproteobacteria / genetics. Betaproteobacteria / growth & development. Ecosystem. Molecular Sequence Data. Phylogeny. Polymerase Chain Reaction. RNA, Ribosomal, 16S / genetics. Sequence Analysis, DNA

  • SILVA. SILVA SSU Database .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Appl Environ Microbiol. 2003 Oct;69(10):5875-83 [14532039.001]
  • [Cites] Appl Environ Microbiol. 2003 Sep;69(9):5248-54 [12957910.001]
  • [Cites] Appl Environ Microbiol. 2003 Nov;69(11):6610-9 [14602620.001]
  • [Cites] Environ Microbiol. 2004 Mar;6(3):242-53 [14871208.001]
  • [Cites] Appl Environ Microbiol. 2004 Mar;70(3):1494-505 [15006771.001]
  • [Cites] Appl Environ Microbiol. 2004 Apr;70(4):2445-51 [15066843.001]
  • [Cites] Nature. 2004 Jul 29;430(6999):551-4 [15282603.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Oct;82(20):6955-9 [2413450.001]
  • [Cites] J Bacteriol. 1991 Jul;173(14):4371-8 [2066334.001]
  • [Cites] Appl Environ Microbiol. 1997 Mar;63(3):983-9 [9055415.001]
  • [Cites] Nucleic Acids Res. 1997 Sep 1;25(17):3389-402 [9254694.001]
  • [Cites] Appl Environ Microbiol. 2000 Feb;66(2):578-87 [10653721.001]
  • [Cites] Science. 2000 Sep 15;289(5486):1902-6 [10988064.001]
  • [Cites] Appl Environ Microbiol. 2000 Nov;66(11):4634-40 [11055904.001]
  • [Cites] Appl Environ Microbiol. 2000 Nov;66(11):5053-65 [11055963.001]
  • [Cites] Nucleic Acids Res. 2001 Jan 1;29(1):173-4 [11125082.001]
  • [Cites] Appl Environ Microbiol. 2002 Jan;68(1):379-88 [11772648.001]
  • [Cites] Appl Environ Microbiol. 2002 Feb;68(2):505-18 [11823184.001]
  • [Cites] Appl Environ Microbiol. 2002 Aug;68(8):3878-85 [12147485.001]
  • [Cites] Appl Environ Microbiol. 2003 Mar;69(3):1442-51 [12620827.001]
  • [Cites] Appl Environ Microbiol. 2003 Jun;69(6):3607-16 [12788769.001]
  • [Cites] Nucleic Acids Res. 2003 Jul 1;31(13):3497-500 [12824352.001]
  • [Cites] Appl Environ Microbiol. 1997 Sep;63(9):3359-66 [9292985.001]
  • [Cites] Appl Environ Microbiol. 1997 Nov;63(11):4237-42 [9361410.001]
  • [Cites] Genome Res. 1998 Mar;8(3):186-94 [9521922.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3807-12 [10097119.001]
  • [Cites] Appl Environ Microbiol. 1999 Jul;65(7):3192-204 [10388721.001]
  • [Cites] Appl Environ Microbiol. 1999 Aug;65(8):3721-6 [10427073.001]
  • [Cites] Appl Environ Microbiol. 2004 Nov;70(11):6753-66 [15528542.001]
  • [Cites] Appl Environ Microbiol. 2005 Aug;71(8):4793-800 [16085877.001]
  • [Cites] Appl Environ Microbiol. 2005 Dec;71(12):8201-6 [16332803.001]
  • [Cites] Appl Environ Microbiol. 2005 Dec;71(12):8402-10 [16332828.001]
  • [Cites] Appl Environ Microbiol. 2006 May;72(5):3489-97 [16672495.001]
  • [Cites] Trends Microbiol. 2006 Jun;14(6):257-63 [16679014.001]
  • [Cites] Ecology. 2006 Aug;87(8):2068-79 [16937646.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13104-9 [16938845.001]
  • [Cites] Appl Environ Microbiol. 2006 Sep;72(9):5734-41 [16957188.001]
  • [Cites] Appl Environ Microbiol. 2006 Sep;72(9):6004-11 [16957222.001]
  • [Cites] Mol Ecol. 2007 Feb;16(4):867-80 [17284217.001]
  • [Cites] Environ Microbiol. 2007 May;9(5):1253-66 [17472638.001]
  • [Cites] Appl Environ Microbiol. 2003 Nov;69(11):6481-8 [14602603.001]
  • (PMID = 18039821.001).
  • [ISSN] 1098-5336
  • [Journal-full-title] Applied and environmental microbiology
  • [ISO-abbreviation] Appl. Environ. Microbiol.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ AY962019/ AY962020/ AY962021/ DQ063002/ DQ063003/ DQ063004/ DQ063005/ DQ063006/ DQ063007/ DQ063008/ DQ063009/ DQ063010/ DQ063011/ DQ063012/ DQ063013/ DQ063014/ DQ063015/ DQ063016/ DQ063017/ DQ063018/ DQ063019/ DQ063020/ DQ063021/ DQ063022/ DQ063023/ DQ063024/ DQ063025/ DQ063026/ DQ063027/ DQ063028/ DQ063029/ DQ063030/ DQ063031/ DQ063032/ DQ063033/ DQ063034/ DQ063035/ DQ063036/ DQ063037/ DQ063038/ DQ063039/ DQ063040/ DQ063041/ DQ063042/ DQ063043/ DQ063044/ DQ063045/ DQ063046/ DQ063047/ DQ063048/ DQ063049/ DQ063050/ DQ063051/ DQ063052/ DQ063053/ DQ063054/ DQ063055/ DQ063056/ DQ063057/ DQ063058/ DQ063059/ DQ063060/ DQ063061/ DQ063062/ DQ063063/ DQ063064/ DQ063065/ DQ063066/ DQ063067/ DQ063068/ DQ063069/ DQ063070/ DQ063071/ DQ063072/ DQ063073/ DQ063101/ DQ063102/ DQ063103/ DQ063104/ DQ063105/ DQ063106/ DQ063107/ DQ063108/ DQ063109/ DQ063110/ DQ063111/ DQ063112/ DQ063113/ DQ063114/ DQ063115/ DQ063116/ DQ063117/ DQ063118/ DQ063119/ DQ063120/ DQ063121/ DQ063122/ DQ063123/ DQ063124/ DQ063125/ DQ063126/ DQ063127/ DQ063128/ DQ063129/ DQ063130/ DQ063131/ DQ063132/ DQ063133/ DQ063134/ DQ063135/ DQ063136/ DQ063137/ DQ063138/ DQ063139/ DQ063140/ DQ063141/ DQ063142/ DQ063143/ DQ063144/ DQ063145/ DQ063146/ DQ063147/ DQ063148/ DQ063149/ DQ063150/ DQ063151/ DQ063152/ DQ063153/ DQ063154/ DQ063155/ DQ063156/ DQ063157/ DQ063158/ DQ063159/ DQ063160/ DQ063161/ DQ063162/ DQ063163/ DQ063164/ DQ063165/ DQ063166/ DQ063167/ DQ063168/ DQ063169/ DQ063170/ DQ063171/ DQ063172/ DQ063173/ DQ063174/ DQ063175/ DQ063176/ DQ063177/ DQ063178/ DQ063179/ DQ063180/ DQ063181/ DQ063182/ DQ063183/ DQ063184/ DQ063185/ DQ063186/ DQ063187/ DQ063188/ DQ063189/ DQ063190/ DQ063191/ DQ063192/ DQ063193/ DQ063194/ DQ063195/ DQ063196/ DQ063197/ DQ063198/ DQ063199/ DQ063200/ DQ063201/ DQ063202/ DQ063203/ DQ063204/ DQ063205/ DQ063206/ DQ063207/ DQ063208/ DQ063209/ DQ063210/ DQ063211/ DQ063212/ DQ063213/ DQ063214/ DQ063215/ DQ063216/ DQ270271/ DQ270272/ DQ270273/ DQ270274/ DQ270275/ DQ270276/ DQ270277/ DQ270278/ DQ270279/ DQ270280/ DQ270281/ DQ270282/ DQ270283/ DQ270284/ DQ270285/ DQ270286/ DQ270287/ DQ270288/ DQ270289/ DQ270290/ DQ270291/ DQ270292/ DQ270293/ DQ270294/ DQ270295/ DQ270296/ EF627821/ EF627822/ EF627823/ EF627824/ EF627825/ EF627826/ EF627827/ EF627828/ EF627829/ EF627830/ EF627831/ EF627832/ EF627833/ EF627834/ EF627835/ EF627836/ EF627837/ EF627838/ EF627839/ EF627840/ EF627841/ EF627842/ EF627843/ EF627844/ EF627845/ EF627846/ EF627847/ EF627848/ EF627849/ EF627850/ EF627851/ EF627852/ EF627853/ EF627854/ EF627855/ EF627856/ EF627857/ EF627858/ EF627859/ EF627860/ EF627861/ EF627862/ EF627863/ EF627864/ EF627865/ EF627866/ EF627867/ EF627868/ EF627869/ EF627870/ EF627871/ EF627872/ EF627873/ EF627874/ EF627875/ EF627876/ EF627877/ EF627878/ EF627879/ EF627880/ EF627881/ EF627882/ EF627883/ EF627884/ EF627885/ EF627886/ EF627887/ EF627888/ EF627889/ EF627890/ EF627891/ EF627892/ EF627893/ EF627894/ EF627895/ EF627896/ EF627897/ EF627898/ EF627899/ EF627900/ EF627901/ EF627902/ EF627903/ EF627904/ EF627905/ EF627906/ EF627907/ EF627908/ EF627909/ EF627910/ EF627911/ EF627912/ EF627913/ EF627914/ EF627915/ EF627916/ EF627917/ EF627918/ EF627919/ EF627920/ EF627921/ EF627922/ EF627923/ EF627924/ EF627925/ EF627926/ EF627927/ EF627928/ EF627929/ EF627930/ EF627931/ EF627932/ EF627933/ EF627934/ EF627935/ EF627936/ EF627937/ EF627938/ EF627939/ EF627940/ EF627941/ EF627942/ EF627943/ EF627944/ EF627945/ EF627946/ EF627947/ EF627948/ EF627949/ EF627950/ EF627951/ EF627952/ EF627953/ EF627954/ EF627955/ EF627956/ EF627957/ EF627958/ EF627959/ EF627960/ EF627961/ EF627962/ EF627963/ EF627964/ EF627965/ EF627966/ EF627967/ EF627968/ EF627969/ EF627970/ EF627971
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Ribosomal, 16S
  • [Other-IDs] NLM/ PMC2223248
  •  go-up   go-down


66. Carydis VB, Walker T, Wing A, Colgan TJ: Utility of p16(ink4a) immunocytochemistry in liquid-based cytology specimens from women treated for high-grade squamous intraepithelial lesions. Acta Cytol; 2007 Jul-Aug;51(4):517-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To examine whether p16(ink4a) immunocytochemical (ICC) expression detected intraepithelial disease in liquid-based cytology (LBC) specimens from women with high-grade squamous intraepithelial lesions (HSIL), whose specimen was labeled negative for intraepithelial lesion or malignany (NILM).
  • STUDY DESIGN: Residual LBC specimens from women treated for HSIL (n = 21), whose LBC test was interpreted as NILM including marked benign inflammatory changes (BCC) were used.
  • In the NILM/BCC group, 2 of 21 with adequate LBC residua were ICC p16(ink4a) positive; on review both were reclassified as epithelial abnormality--1 HSIL and 1 atypical squamous cells cannot exclude HSIL.
  • [MeSH-major] Cervical Intraepithelial Neoplasia / metabolism. Cyclin-Dependent Kinase Inhibitor p16 / metabolism. Neoplasms, Squamous Cell / metabolism. Uterine Cervical Neoplasms / metabolism. Vaginal Smears


67. Wagoner J, Keehn C, Morgan MB: CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma. Am J Dermatopathol; 2007 Dec;29(6):555-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma.
  • Basal cell carcinoma and squamous cell carcinoma are common entities in clinical practice.
  • We sought to determine if the CD10 immunostain could have diagnostic utility in distinguishing between early superficial basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).
  • CD10 was negative in the tumor cells in 13 out of 13 superficially invasive SCCs and SCC in situ.
  • [MeSH-major] Biomarkers, Tumor / analysis. Carcinoma in Situ / diagnosis. Carcinoma, Basal Cell / diagnosis. Carcinoma, Squamous Cell / diagnosis. Neprilysin / analysis. Skin Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18032951.001).
  • [ISSN] 1533-0311
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 3.4.24.11 / Neprilysin
  •  go-up   go-down


68. Oven Ustaalioglu BB, Bilici A, Kefeli U, Seker M, Yildirim E, Salepci T, Oncel M, Kement M, Gumus M: Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences. Oncology; 2010;79(1-2):105-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences.
  • In the current study, we evaluated whether the metastatic lymph node ratio (n ratio) is important in predicting disease-free survival (DFS) for breast cancer patients.
  • [MeSH-major] Breast Neoplasms / mortality. Breast Neoplasms / pathology. Lymph Nodes / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Axilla. Biomarkers, Tumor / analysis. Disease-Free Survival. Female. Humans. Inflammatory Breast Neoplasms / mortality. Inflammatory Breast Neoplasms / pathology. Kaplan-Meier Estimate. Lymph Node Excision. Lymphatic Metastasis. Middle Aged. Necrosis. Neoadjuvant Therapy / methods. Neoplasm Invasiveness. Neoplasm Staging. Predictive Value of Tests. Prognosis. Proportional Hazards Models. Retrospective Studies. Risk Assessment. Risk Factors

  • Genetic Alliance. consumer health - Breast Cancer.
  • Genetic Alliance. consumer health - Metastatic cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 S. Karger AG, Basel.
  • (PMID = 21088436.001).
  • [ISSN] 1423-0232
  • [Journal-full-title] Oncology
  • [ISO-abbreviation] Oncology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


69. Ma C, Quesnelle KM, Sparano A, Rao S, Park MS, Cohen MA, Wang Y, Samanta M, Kumar MS, Aziz MU, Naylor TL, Weber BL, Fakharzadeh SS, Weinstein GS, Vachani A, Feldman MD, Brose MS: Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues. Cancer Biol Ther; 2009 May;8(10):907-16
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Cub and Sushi Multiple Domains-1 (CSMD1) is a tumor suppressor gene on 8p23.2, where allelic loss is both frequent and associated with poor prognosis in head and neck squamous cell carcinoma (HNSCC).
  • To understand the extent of CSMD1 aberrations in vivo, we characterized 184 primary tumors from the head and neck, lung, breast and skin for gene copy number and analyzed expression in our HNSCCs and lung squamous cell carcinomas (SCCs).
  • We detected loss of CSMD1 in a large proportion of HNSCCs (50%), lung (46%) and breast cancers (55%), and to a lesser extent in cutaneous SCCs (29%) and basal cell carcinomas (BCCs, 17%) using array-based comparative genomic hybridization (aCGH).
  • CSMD1 expression was decreased in tumors compared to adjacent benign tissue (65%, 13/20) and was likely due to gene loss in 45% of cases (9/20).
  • [MeSH-major] Breast Neoplasms / genetics. Head and Neck Neoplasms / genetics. Lung Neoplasms / genetics. Membrane Proteins / genetics. Skin Neoplasms / genetics
  • [MeSH-minor] Carcinoma, Squamous Cell / genetics. Carcinoma, Squamous Cell / pathology. Case-Control Studies. Chromosome Deletion. Comparative Genomic Hybridization. DNA, Neoplasm / analysis. Female. Gene Dosage. Gene Expression. Humans. Loss of Heterozygosity. Mouth Neoplasms / genetics. RNA, Messenger / genetics. RNA, Messenger / metabolism


70. Lee B, Lim A, Lalvani A, Descamps MJ, Leonard R, Nallamala S, Lewis JS, Coombes RC, Stebbing J: The clinical significance of radiologically detected silent pulmonary nodules in early breast cancer. Ann Oncol; 2008 Dec;19(12):2001-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Those in whom indeterminate pulmonary nodules are visualized without the presence of other metastatic lesions represent a clinical dilemma regarding their management as early breast cancer or metastatic disease.
  • Those with obvious metastatic disease were excluded.
  • CONCLUSIONS: Breast cancer cases with subcentimeter indeterminate pulmonary lesions and no evidence of metastases elsewhere are unlikely to represent metastatic disease.

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 1992 Nov;10(11):1810-6 [1403062.001]
  • [Cites] Surgery. 1984 Oct;96(4):801-5 [6484816.001]
  • [Cites] Radiology. 2005 Nov;237(2):395-400 [16244247.001]
  • [Cites] Thorax. 2006 Apr;61(4):331-6 [16467070.001]
  • [Cites] J Clin Oncol. 2006 Jun 20;24(18):2694-6 [16702578.001]
  • [Cites] J Clin Oncol. 2006 Jun 20;24(18):2743-9 [16702580.001]
  • [Cites] Clin Evid. 2006 Jun;(15):2331-59 [16973089.001]
  • [Cites] Clin Evid. 2006 Jun;(15):2360-92 [16973090.001]
  • [Cites] J Clin Oncol. 2006 Oct 20;24(30):4793-5 [17050863.001]
  • [Cites] J Clin Oncol. 2006 Oct 20;24(30):4801-7 [17050865.001]
  • [Cites] Lancet. 2007 Feb 17;369(9561):559-70 [17307102.001]
  • [Cites] J Clin Oncol. 2007 Apr 10;25(11):1454-5 [17416872.001]
  • [Cites] Thorac Surg Clin. 2007 May;17(2):143-58 [17626393.001]
  • [Cites] Chest. 2007 Sep;132(3 Suppl):108S-130S [17873164.001]
  • [Cites] Chest. 2007 Dec;132(6):1939-48 [18079227.001]
  • [Cites] Radiol Clin North Am. 2000 May;38(3):511-24 [10855258.001]
  • [Cites] Lancet. 2000 Aug 12;356(9229):590-1; author reply 593 [10950250.001]
  • [Cites] J Thorac Imaging. 2001 Jan;16(1):65-8 [11149694.001]
  • [Cites] JAMA. 2001 Feb 21;285(7):914-24 [11180735.001]
  • [Cites] Radiol Clin North Am. 2001 Nov;39(6):1115-35 [11699664.001]
  • [Cites] Lung Cancer. 2002 Feb;35(2):143-8 [11804686.001]
  • [Cites] N Engl J Med. 2004 Mar 11;350(11):1081-92 [15014181.001]
  • [Cites] Radiology. 2004 Apr;231(1):164-8 [14990809.001]
  • [Cites] Chest. 2004 Apr;125(4):1522-9 [15078769.001]
  • [Cites] J Thorac Imaging. 1994 Spring;9(2):129-34 [8207780.001]
  • (PMID = 18641008.001).
  • [ISSN] 1569-8041
  • [Journal-full-title] Annals of oncology : official journal of the European Society for Medical Oncology
  • [ISO-abbreviation] Ann. Oncol.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2733112
  •  go-up   go-down


71. Sanguinetti A, Ragusa M, De Falco M, Sperlongano P, Calzolari F, Parmeggiani D, Misso C, Piatto A, Parmeggiani U, Avenia N: [Locally advanced breast cancer in elderly patients: treatment standardised or tailored to individual needs?]. Chir Ital; 2007 Nov-Dec;59(6):829-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Furthermore, for organizational and social reasons, the incidence of locally advanced neoplasms is higher in this age group than in the younger population.
  • Eight of the 34 patients discharged died within 24 months (2 of disease progression).
  • 10 of the 26 patients (38.4%) surviving over 2 years underwent redo surgery for local relapse of disease.
  • 2) disease management cannot be standardized, but must be tailored to the single patient;.
  • [MeSH-major] Breast Neoplasms / surgery. Mastectomy, Modified Radical
  • [MeSH-minor] Age Factors. Aged. Aged, 80 and over. Antineoplastic Agents, Hormonal / therapeutic use. Breast / pathology. Female. Follow-Up Studies. Humans. Infant, Newborn. Neoplasm Recurrence, Local / surgery. Neoplasm Staging. Reoperation. Tamoxifen / therapeutic use. Time Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • Hazardous Substances Data Bank. TAMOXIFEN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18360988.001).
  • [ISSN] 0009-4773
  • [Journal-full-title] Chirurgia italiana
  • [ISO-abbreviation] Chir Ital
  • [Language] ita
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal; 094ZI81Y45 / Tamoxifen
  •  go-up   go-down


72. Palmero EI, Ashton-Prolla P, da Rocha JC, Vargas FR, Kalakun L, Blom MB, Azevedo SJ, Caleffi M, Giugliani R, Schüler-Faccini L: Clinical characterization and risk profile of individuals seeking genetic counseling for hereditary breast cancer in Brazil. J Genet Couns; 2007 Jun;16(3):363-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] BRCA2 Protein / genetics. Breast Neoplasms / genetics. Genetic Counseling / statistics & numerical data. Genetic Testing / statistics & numerical data. Neoplastic Syndromes, Hereditary / genetics. Ubiquitin-Protein Ligases / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Apoptosis Regulatory Proteins. Brazil. Cross-Sectional Studies. DNA Mutational Analysis. Female. Heterozygote Detection. Humans. Middle Aged. Ovarian Neoplasms / epidemiology. Ovarian Neoplasms / genetics. Probability. Risk. Risk Assessment. Socioeconomic Factors


73. Suda W, Nagasaki A, Shishido M: Powdery mildew-infection changes bacterial community composition in the phyllosphere. Microbes Environ; 2009;24(3):217-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To investigate changes in bacterial communities associated with a fungal foliar disease, epiphytic bacteria from powdery mildew-infected and uninfected leaves of cucumber and Japanese spindle were analyzed using both culture-dependent and -independent methods.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21566376.001).
  • [ISSN] 1342-6311
  • [Journal-full-title] Microbes and environments
  • [ISO-abbreviation] Microbes Environ.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


74. Capalbo C, Ricevuto E, Vestri A, Ristori E, Sidoni T, Buffone O, Adamo B, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A, Giannini G: BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models. Ann Oncol; 2006 Jun;17 Suppl 7:vii34-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Breast cancer is an extremely complex disease, characterized by a progressive multistep process caused by interactions of both genetic and non-genetic factors.


75. Zhu ZY, Zhang HW, Xu SF, Chen JL, Wu GH, Zhang B, Zhang XX: Intrinsic anisotropy of degree of transport spin polarization in typical ferromagnets. J Phys Condens Matter; 2008 Jul 9;20(27):275245
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intrinsic anisotropy of degree of transport spin polarization in typical ferromagnets.
  • A general approach is presented for investigation of the anisotropy of the degree of transport spin polarization (P) in ferromagnets both in the ballistic regime, P(1,i), and in the diffusive regime, P(2,i), as a function of crystal direction.
  • The validity of this approach is confirmed by the benchmark calculation for the isotropic P.
  • By this approach, we have investigated the anisotropy of P in bcc Fe, fcc Co, fcc Ni and hcp Co.
  • For cubic structures, P(1,i) shows a small but appreciable anisotropy, due to the difference in the electronic orbital extension for spin-up and spin-down conduction bands.
  • However, P(2,i) shows an isotropic feature for the cubic structure, as a result of the combination of its dependence on the square of electron velocity and the lattice symmetry.
  • On the other hand, for hcp Co, both P(1,i) and P(2,i) show a very strong anisotropy.
  • The large anisotropy of P(1,i) and P(2,i) in hcp Co is mainly attributed to the anisotropy of spin-down ballistic (diffusive) conductance.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21694406.001).
  • [ISSN] 0953-8984
  • [Journal-full-title] Journal of physics. Condensed matter : an Institute of Physics journal
  • [ISO-abbreviation] J Phys Condens Matter
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


76. Ahlgrimm-Siess V, Horn M, Koller S, Ludwig R, Gerger A, Hofmann-Wellenhof R: Monitoring efficacy of cryotherapy for superficial basal cell carcinomas with in vivo reflectance confocal microscopy: a preliminary study. J Dermatol Sci; 2009 Jan;53(1):60-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Monitoring efficacy of cryotherapy for superficial basal cell carcinomas with in vivo reflectance confocal microscopy: a preliminary study.
  • Non-invasive treatment modalities, such as cryotherapy have been employed for sBCCs, all failing to provide tissue for confirming diagnosis and assessing adequacy of tumour removal.
  • Reflectance confocal microscopy (RCM), a new non-invasive imaging technique has proven to be a useful tool for detection of basal cell carcinoma in vivo.
  • Tumour clearance was assessed by RCM imaging 3 months after therapy followed by histopathologic examination.
  • Five hours after cryotherapy, all 10 sBCCs showed small bright round to polygonal structures at basal layer and black round to oval areas of varying size with such bright structures floating therein, correlating to cell necrosis and incipient blistering.
  • Eight sBCCs showed also cell necrosis in upper dermis.
  • Tumour clearance on later histopathologic examination was only proven in those lesions showing damage to the upper dermis after 5h with RCM.
  • CONCLUSION: Early cell necrosis within upper dermal structures seems to correlate with ablation of overlying tumour tissue.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Carcinoma, Basal Cell / therapy. Cryotherapy / methods. Microscopy, Confocal. Skin Neoplasms / pathology. Skin Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18829267.001).
  • [ISSN] 0923-1811
  • [Journal-full-title] Journal of dermatological science
  • [ISO-abbreviation] J. Dermatol. Sci.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


77. Ellis NA, Kirchhoff T, Mitra N, Ye TZ, Chuai S, Huang H, Nafa K, Norton L, Neuhausen S, Gordon D, Struewing JP, Narod S, Offit K: Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping. Genet Epidemiol; 2006 Jan;30(1):48-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We studied the feasibility of a novel approach to localize breast cancer susceptibility genes, using a low-density genome-wide panel of single-nucleotide polymorphisms and taking advantage of large regions of linkage disequilibrium (LD) flanking Jewish disease genes in high-risk cases.
  • With Affymetrix GeneChip arrays, we genotyped 8,576 polymorphisms in three sets of Ashkenazi Jewish breast cancer cases: a "validation" set of 27 breast cancer cases, all of whom carried the BRCA2*6174delT founder mutation; a "field" set of 19 breast cancer cases from male breast cancer kindreds, which simulated conditions for finding new genes; and a "test" set of 57 probands from breast cancer kindreds (4 or more cases/kindred), in which mutations in BRCA1 and BRCA2 had been excluded.

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 Wiley-Liss, Inc.
  • (PMID = 16206141.001).
  • [ISSN] 0741-0395
  • [Journal-full-title] Genetic epidemiology
  • [ISO-abbreviation] Genet. Epidemiol.
  • [Language] ENG
  • [Grant] United States / NHGRI NIH HHS / HG / K01-HG-00055; United States / NCI NIH HHS / CA / CA 103394; United States / NHLBI NIH HHS / HL / R01-HL56778; United States / NCI NIH HHS / CA / R03 CA103500-02; United States / NCI NIH HHS / CA / R03 CA103500; United States / NCI NIH HHS / CA / CA103500-02; United States / NIMH NIH HHS / MH / MH44292
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


78. Shibuta Y, Suzuki T: A molecular dynamics study of the phase transition in bcc metal nanoparticles. J Chem Phys; 2008 Oct 14;129(14):144102
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • On the other hand, the depression of the nucleation temperature during cooling was not monotonic with respect to the particle radius since the nucleation from an undercooled liquid depends on the event probability of an embryo or a nucleus.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19045129.001).
  • [ISSN] 1089-7690
  • [Journal-full-title] The Journal of chemical physics
  • [ISO-abbreviation] J Chem Phys
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


79. Hirt RA, Vondrakova K, de Arespacochaga AG, Gütl A, van den Hoven R: Effects of cadmium chloride inhalation on airflow limitation to histamine, carbachol and adenosine 5'-monophosphate assessed by barometric whole body plethysmography in healthy dogs. Vet J; 2007 Jan;173(1):62-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effects of cadmium chloride inhalation on airflow limitation to histamine, carbachol and adenosine 5'-monophosphate assessed by barometric whole body plethysmography in healthy dogs.
  • The effects of pharmacological bronchoprovocation on airflow patterns and surrogate respiratory parameters assessed by barometric whole body plethysmography (BWBP) were investigated in healthy dogs, previously exposed to cadmium chloride inhalation.
  • BWBP-derived respiratory variables were calculated (1) at baseline and (2) following nebulisation of increasing concentrations of histamine, carbachol and adenosine 5'-monophosphate (AMP) until enhanced pause (PENH) increased to 300% of baseline (PCPENH300).
  • Bronchoalveolar lavage fluid (BALF) cytology before (BCC) and after (ACC) cadmium chloride inhalation revealed cadmium-induced airway inflammation.
  • Neutrophils increased from 6.7 +/- 7.3% (728 +/- 104/microL) BCC to 77.8 +/- 8.6% (3255 +/- 1407/microL) ACC.
  • PCPENH300 for all three agonists significantly decreased ACC (means+/-SD) as follows: PCPENH300(histamine) 0.72 +/- 0.28 mg/mL BCC, and 0.35 +/- 0.31 mg/mL ACC (P<0.02); PCPENH300(carbachol) 0.34 +/- 0.16 mg/mL BCC, and 0.064 +/- 0.032 mg/mL ACC (P<0.02); PCPENH300(AMP) 1000 mg/mL BCC, and 415 +/- 398 mg/mL ACC (P<0.03).
  • The only clinical sign shown was coughing.
  • It was concluded that airway hyperresponsiveness after induced airway inflammation can be determined by BWBP in conscious small sized dogs.
  • BWBP could be a suitable technique to study the respiratory effects of urban environmental pollution in pets.
  • [MeSH-major] Adenosine Monophosphate / toxicity. Cadmium Chloride / administration & dosage. Cadmium Chloride / toxicity. Carbachol / toxicity. Health. Histamine / toxicity. Plethysmography, Whole Body / veterinary
  • [MeSH-minor] Administration, Inhalation. Animals. Bronchial Spasm / chemically induced. Bronchial Spasm / veterinary. Dogs. Female. Inflammation / chemically induced. Inflammation / veterinary. Male

  • Hazardous Substances Data Bank. CADMIUM CHLORIDE .
  • Hazardous Substances Data Bank. HISTAMINE .
  • Hazardous Substances Data Bank. CARBACHOL CHLORIDE .
  • Hazardous Substances Data Bank. ADENOSINE 5'-PHOSPHATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16314130.001).
  • [ISSN] 1090-0233
  • [Journal-full-title] Veterinary journal (London, England : 1997)
  • [ISO-abbreviation] Vet. J.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 415SHH325A / Adenosine Monophosphate; 820484N8I3 / Histamine; 8Y164V895Y / Carbachol; J6K4F9V3BA / Cadmium Chloride
  •  go-up   go-down


80. Choi DH, Cho DY, Lee MH, Park HS, Ahn SH, Son BH, Haffty BG: The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation. Breast Cancer Res Treat; 2008 Dec;112(3):569-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / genetics. Genes, BRCA1. Genes, BRCA2. Mutation. Protein-Serine-Threonine Kinases / genetics

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18175216.001).
  • [ISSN] 1573-7217
  • [Journal-full-title] Breast cancer research and treatment
  • [ISO-abbreviation] Breast Cancer Res. Treat.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] EC 2.7.1.11 / Checkpoint Kinase 2; EC 2.7.11.1 / CHEK2 protein, human; EC 2.7.11.1 / Protein-Serine-Threonine Kinases
  •  go-up   go-down


81. Welsh MM, Applebaum KM, Spencer SK, Perry AE, Karagas MR, Nelson HH: CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer. Cancer Res; 2009 Aug 1;69(15):6158-63
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Due to the inverse relationship between tumor surveillance and autoimmunity, we hypothesize that the same genetic variant in the CTLA4 locus that increases risk for autoimmune diseases is associated with decreased risk of non-melanoma skin cancer (NMSC).
  • We analyzed whether the polymorphism CT60 or haplotypes of CTLA4 influence odds of developing the major types of NMSC, basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), in a population-based case-control study of Caucasians in New Hampshire (849 controls, 930 BCC, and 713 SCC).
  • There were significantly decreased odds of disease associated with two haplotypes, which possess the CT60 G allele.

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cell Immunol. 1977 Jun 1;31(1):182-7 [872221.001]
  • [Cites] J Natl Cancer Inst. 1976 Jul;57(1):211-5 [1003502.001]
  • [Cites] Immunology. 1981 Jul;43(3):527-33 [7251064.001]
  • [Cites] J Invest Dermatol. 1991 Oct;97(4):729-34 [1940446.001]
  • [Cites] Int J Cancer. 1999 May 17;81(4):555-9 [10225444.001]
  • [Cites] J Natl Cancer Inst. 1999 Jun 2;91(11):911-3 [10359543.001]
  • [Cites] Annu Rev Immunol. 2005;23:515-48 [15771580.001]
  • [Cites] Immunol Rev. 2005 Apr;204:102-15 [15790353.001]
  • [Cites] Eur J Immunol. 2005 Jul;35(7):2157-62 [15940668.001]
  • [Cites] Cancer Genet Cytogenet. 2006 Mar;165(2):114-20 [16527605.001]
  • [Cites] J Clin Oncol. 2006 Jul 20;24(21):3483-9 [16849765.001]
  • [Cites] Immunol Rev. 2006 Aug;212:131-48 [16903911.001]
  • [Cites] Carcinogenesis. 2008 Oct;29(10):1950-4 [18641401.001]
  • [Cites] Hum Immunol. 2007 Aug;68(8):698-704 [17678726.001]
  • [Cites] J Immunol. 1999 Dec 15;163(12):6725-31 [10586070.001]
  • [Cites] J Exp Med. 2000 Jul 17;192(2):303-10 [10899917.001]
  • [Cites] J Immunol. 2000 Aug 15;165(4):1824-31 [10925260.001]
  • [Cites] Nature. 2003 May 29;423(6939):506-11 [12724780.001]
  • [Cites] J Natl Cancer Inst. 1974 Nov;53(5):1333-6 [4139281.001]
  • [Cites] Adv Exp Med Biol. 1976;66:445-9 [1266675.001]
  • [Cites] Cell Immunol. 1978 Jun;38(1):105-15 [667953.001]
  • (PMID = 19622768.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA057494; United States / NCI NIH HHS / CA / R01 CA057494; United States / NCI NIH HHS / CA / CA08235; United States / NCI NIH HHS / CA / R01 CA057494-16; United States / NCI NIH HHS / CA / R01 CA082354
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / CTLA-4 Antigen; 0 / CTLA4 protein, human
  • [Other-IDs] NLM/ NIHMS216796; NLM/ PMC2928067
  •  go-up   go-down


82. van der Pols JC, Heinen MM, Hughes MC, Ibiebele TI, Marks GC, Green AC: Serum antioxidants and skin cancer risk: an 8-year community-based follow-up study. Cancer Epidemiol Biomarkers Prev; 2009 Apr;18(4):1167-73
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Antioxidant nutrients can help prevent skin damage caused by ultraviolet radiation from sunlight, but it is not clear whether serum concentrations of such nutrients influence skin cancer risk.
  • METHODS: We carried out a prospective study of the associations between serum concentrations of antioxidant nutrients and incidence (person-based and tumor-based) of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) of the skin among a random subsample of 485 adults from an Australian community.
  • RESULTS: Although there were no associations between baseline serum carotenoids or alpha-tocopherol concentrations and incidence of BCC or SCC, baseline serum selenium concentrations showed strong inverse associations with both BCC and SCC tumor incidence.
  • CONCLUSION: Relatively high serum selenium concentrations are associated with an approximately 60% decrease in subsequent tumor incidence of both BCC and SCC, whereas serum concentrations of carotenoids or alpha-tocopherol are not associated with later skin cancer incidence.
  • [MeSH-major] Antioxidants / metabolism. Biomarkers, Tumor / blood. Carotenoids / blood. Selenium Compounds / blood. Skin Neoplasms / epidemiology. alpha-Tocopherol / blood
  • [MeSH-minor] Aged. Australia / epidemiology. Carcinoma, Basal Cell / blood. Carcinoma, Basal Cell / epidemiology. Carcinoma, Squamous Cell / blood. Carcinoma, Squamous Cell / epidemiology. Cohort Studies. Female. Follow-Up Studies. Humans. Incidence. Longitudinal Studies. Male. Middle Aged. Prospective Studies. Risk Assessment

  • MedlinePlus Health Information. consumer health - Antioxidants.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. SELENIUM COMPOUNDS .
  • Hazardous Substances Data Bank. VITAMIN E .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19336544.001).
  • [ISSN] 1055-9965
  • [Journal-full-title] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • [ISO-abbreviation] Cancer Epidemiol. Biomarkers Prev.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antioxidants; 0 / Biomarkers, Tumor; 0 / Selenium Compounds; 36-88-4 / Carotenoids; H4N855PNZ1 / alpha-Tocopherol
  •  go-up   go-down


83. Osiecka B, Jurczyszyn K, Symonowicz K, Bronowicz A, Ostasiewicz P, Czapińska E, Hotowy K, Krzystek-Korpacka M, Gebarowska E, Izykowska I, Dziegiel P, Terlecki G, Ziółkowski P: In vitro and in vivo matrix metalloproteinase expression after photodynamic therapy with a liposomal formulation of aminolevulinic acid and its methyl ester. Cell Mol Biol Lett; 2010 Dec;15(4):630-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Photodynamic therapy (PDT) is a well-known method for the treatment of malignant tumors, and its principles have been well established over the past 30 years.
  • Topical photodynamic therapy with aminolevulinic acid (5-ALA) is an alternative therapy for many malignant processes, including nonmelanoma skin cancers such as basal-cell carcinoma (BCC).
  • Our novel approach for this study was to use a liposomal formulation of 5-ALA and its methyl ester (commercially available as metvix) both in vitro and in vivo, and to check whether the liposome-entrapped precursors of photosensitizers can induce the expression of metalloproteinases (MMPs) in animal tumor cells and in other tissues from tumor-bearing rats and in selected cell lines in vitro.
  • We also checked whether the application of tissue inhibitors of matrix metalloproteinases (TIMPs) has any effect on MMPs in the above-mentioned experimental models, and if they can cause complete inhibition of MMP expression.
  • After the PDT in tumor-bearing rats, MMP-3 was expressed in the tumor cells with the highest intensity of staining in the tissues directly adjacent to the tumors, while MMP-2 and -9 were not found.
  • [MeSH-major] Aminolevulinic Acid / analogs & derivatives. Cell Line, Tumor / drug effects. Liposomes. Matrix Metalloproteinases / metabolism. Photochemotherapy / methods. Photosensitizing Agents
  • [MeSH-minor] Animals. Breast Neoplasms / drug therapy. Breast Neoplasms / enzymology. Breast Neoplasms / radiotherapy. Cell Survival / drug effects. Female. Humans. Isoenzymes / metabolism. Rats. Rats, Wistar. Tissue Distribution

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20865364.001).
  • [ISSN] 1689-1392
  • [Journal-full-title] Cellular & molecular biology letters
  • [ISO-abbreviation] Cell. Mol. Biol. Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Isoenzymes; 0 / Liposomes; 0 / Photosensitizing Agents; 0 / methyl 5-aminolevulinate; 88755TAZ87 / Aminolevulinic Acid; EC 3.4.24.- / Matrix Metalloproteinases
  •  go-up   go-down


84. Ramirez KS, Lauber CL, Knight R, Bradford MA, Fierer N: Consistent effects of nitrogen fertilization on soil bacterial communities in contrasting systems. Ecology; 2010 Dec;91(12):3463-70; discussion 3503-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Consistent effects of nitrogen fertilization on soil bacterial communities in contrasting systems.
  • Ecosystems worldwide are receiving increasing amounts of reactive nitrogen (N) through anthropogenic activities.
  • Although the effects of increased N inputs on plant communities have been reasonably well studied, few comparable studies have examined impacts on whole soil bacterial communities, though they play critical roles in ecosystem functioning.
  • We sampled soils from two long-term ecological research (LTER) experimental N gradients, both of which have been amended with NH4NO3; a grassland at Cedar Creek (27 years of N additions) and an agricultural field at Kellogg Biological Station (8 years of N additions).
  • By examining shifts in bacterial communities across these contrasting ecosystem types, we could test competing hypotheses about the direct and indirect factors that might drive bacterial responses to elevated N inputs.
  • Bacterial community structure was highly responsive to N additions.
  • We observed predictable and consistent changes in the structure of the bacterial communities across both ecosystem types.
  • Our results suggest that bacterial communities across these gradients are more structured by N and/or soil carbon availability than by shifts in the plant community or soil pH associated with the elevated nitrogen inputs.
  • In contrast to the pronounced shifts in bacterial community composition and in direct contrast to the patterns often observed in plant communities, increases in N availability did not have consistent effects on the richness and diversity of soil bacterial communities.
  • [MeSH-major] Bacteria / isolation & purification. Fertilizers. Nitrogen / metabolism. Soil Microbiology
  • [MeSH-minor] Ecosystem. Michigan. Minnesota. Phylogeny. RNA, Bacterial / genetics. RNA, Ribosomal, 16S / genetics

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Nitrogen, Elemental .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Ecology. 2011 Jun;92(6):1384
  • (PMID = 21302816.001).
  • [ISSN] 0012-9658
  • [Journal-full-title] Ecology
  • [ISO-abbreviation] Ecology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fertilizers; 0 / RNA, Bacterial; 0 / RNA, Ribosomal, 16S; N762921K75 / Nitrogen
  •  go-up   go-down


85. Humbert JF, Dorigo U, Cecchi P, Le Berre B, Debroas D, Bouvy M: Comparison of the structure and composition of bacterial communities from temperate and tropical freshwater ecosystems. Environ Microbiol; 2009 Sep;11(9):2339-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of the structure and composition of bacterial communities from temperate and tropical freshwater ecosystems.
  • We used a partial 16S rRNA sequencing approach to compare the structure and composition of the bacterial communities in three large, deep subalpine lakes in France with those of communities in six shallow tropical reservoirs in Burkina Faso.
  • Despite the very different characteristics of these ecosystems, we found that their bacterial communities share the same composition in regard to the relative proportions of the different phyla, suggesting that freshwater environmental conditions lead to convergence in this composition.
  • In the same way, we found no significant difference in the richness and diversity of the bacterial communities in France and Burkina Faso.
  • We defined core and satellite operational taxonomic units (OTUs) (sequences sharing at least 98% identity) on the basis of their abundance and their geographical distribution.
  • The core OTUs were found either ubiquitously or only in temperate or tropical and subtropical areas, and they contained more than 70% of all the sequences retrieved in this study.
  • In contrast, satellite OTUs were characterized by having a more restricted geographical distribution and by lower abundance.
  • Finally, the bacterial community composition of these freshwater ecosystems in France and Burkina Faso was markedly different, showing that the history of these ecosystems and regional environmental parameters have a greater impact on the relative abundances of the different OTUs in each bacterial community than the local environmental conditions.
  • [MeSH-major] Bacteria / classification. Fresh Water / microbiology
  • [MeSH-minor] Biodiversity. Burkina Faso. France. Geography. Phylogeny. RNA, Ribosomal, 16S / analysis. Temperature. Tropical Climate

  • SILVA. SILVA SSU Database .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19508336.001).
  • [ISSN] 1462-2920
  • [Journal-full-title] Environmental microbiology
  • [ISO-abbreviation] Environ. Microbiol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Ribosomal, 16S
  •  go-up   go-down


86. Lü YL, Zhong M, Liu L, Wei LX, Zhao P: [Clinicopathologic significance of chromosome 17 polysomy in breast cancer]. Zhonghua Bing Li Xue Za Zhi; 2008 Feb;37(2):88-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / genetics. Carcinoma, Ductal / genetics. Chromosome Aberrations. Chromosomes, Human, Pair 17 / genetics. Gene Amplification. Genes, erbB-2 / genetics


87. van de Wiele T, Boon N, Possemiers S, Jacobs H, Verstraete W: Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J Appl Microbiol; 2007 Feb;102(2):452-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects.
  • AIMS: We assessed to what extent fructans of different degrees of polymerization (DP) differ in their prebiotic effectiveness towards in vitro microbial communities from the proximal and distal colon.
  • METHODS AND RESULTS: Two short chain fructans - oligofructose (DP 2-20) and inulin (DP 3-60) - were administered to the Simulator of the Human Intestinal Microbial Ecosystem (SHIME) at 2.5 g day(-1).
  • The influence of fructan addition towards fermentation activity and microbial community composition from the different SHIME colon compartments were evaluated.
  • Both fructans exerted prebiotic effects with significantly higher butyrate and propionate production and stimulation of lactic acid-producing bacteria.
  • Compared with oligofructose, it was noted that it took more time before significant effects from inulin addition were observed.
  • Yet, the higher short-chain fatty acid production and lower proteolytic activity showed that the prebiotic effects from inulin were more pronounced than oligofructose.
  • Also, the bifidogenic effects from inulin vs oligofructose were higher in the distal colon compartments and this effect was prolonged in the distal colon once the addition was stopped.
  • CONCLUSIONS: Inulin has more pronounced prebiotic effects than oligofructose towards both fermentation activity and bacterial community composition in the SHIME model.
  • SIGNIFICANCE AND IMPACT OF THE STUDY: Its slower fermentation rate and higher prebiotic potency makes inulin a more interesting compound than oligofructose to beneficially influence the microbial community from both the proximal and distal colon regions.
  • [MeSH-major] Colon / microbiology. Dietary Fiber / pharmacology. Fructans / pharmacology. Probiotics
  • [MeSH-minor] Bifidobacterium / genetics. Bifidobacterium / physiology. Chicory. Colony Count, Microbial. DNA Fingerprinting. Fatty Acids, Volatile / analysis. Fermentation. Humans. Inulin / chemistry. Inulin / pharmacology. Oligosaccharides / chemistry. Oligosaccharides / pharmacology. Polymers

  • MedlinePlus Health Information. consumer health - Dietary Fiber.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17241351.001).
  • [ISSN] 1364-5072
  • [Journal-full-title] Journal of applied microbiology
  • [ISO-abbreviation] J. Appl. Microbiol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Fatty Acids, Volatile; 0 / Fructans; 0 / Oligosaccharides; 0 / Polymers; 0 / oligofructose; 9005-80-5 / Inulin
  •  go-up   go-down


88. Newman EA, Cimmino VM, Sabel MS, Diehl KM, Frey KA, Chang AE, Newman LA: Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Ann Surg Oncol; 2006 Jan;13(1):52-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A subset of these represents biologically aggressive disease, yet prognostic features for identifying this high-risk category are lacking.
  • [MeSH-major] Breast Neoplasms / pathology. Sentinel Lymph Node Biopsy
  • [MeSH-minor] Adult. Aged. Axilla. Chi-Square Distribution. Female. Humans. Lymph Node Excision. Lymphatic Metastasis. Mastectomy, Segmental. Middle Aged. Neoplasm Recurrence, Local. Prognosis. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16372155.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


89. Langsenlehner T, Renner W, Yazdani-Biuki B, Langsenlehner U: Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Breast Cancer Res Treat; 2008 Feb;107(3):459-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / genetics. Methylenetetrahydrofolate Reductase (NADPH2) / genetics. Polymorphism, Genetic

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Breast Cancer Res Treat. 2007 Dec;106(2):263-71 [17260091.001]
  • (PMID = 17453338.001).
  • [ISSN] 0167-6806
  • [Journal-full-title] Breast cancer research and treatment
  • [ISO-abbreviation] Breast Cancer Res. Treat.
  • [Language] eng
  • [Publication-type] Comment; Letter
  • [Publication-country] Netherlands
  • [Chemical-registry-number] EC 1.5.1.20 / Methylenetetrahydrofolate Reductase (NADPH2)
  •  go-up   go-down


90. López AM, Graham AR, Barker GP, Richter LC, Krupinski EA, Lian F, Grasso LL, Miller A, Kreykes LN, Henderson JT, Bhattacharyya AK, Weinstein RS: Virtual slide telepathology enables an innovative telehealth rapid breast care clinic. Semin Diagn Pathol; 2009 Nov;26(4):177-86
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Virtual slide telepathology enables an innovative telehealth rapid breast care clinic.
  • An innovative telemedicine-enabled rapid breast care service is described that bundles telemammography, telepathology, and teleoncology services into a single day process.
  • The service is called the UltraClinics Process.
  • Since the core services are at four different physical locations a challenge has been to obtain STAT second opinion readouts on newly diagnosed breast cancer cases.
  • In order to provide same day QA re-review of breast surgical pathology cases, a DMetrix DX-40 ultrarapid virtual slide scanner (DMetrix, Inc., Tucson, AZ) was installed at the participating laboratory.
  • Glass slides of breast cancer and breast hyperplasia cases were scanned the same day the slides were produced by the University Physicians Healthcare Hospital histology laboratory.
  • Virtual slide telepathology was used for STAT quality assurance readouts at University Medical Center, 6 miles away.
  • There was complete concurrence with the primary diagnosis in 139 (90.3%) of cases.
  • There were 4 (2.3%) major discrepancies, which would have resulted in a different therapy and 3 (1.9%) minor discrepancies.
  • Three cases (1.9%) were deferred for immunohistochemistry.
  • In 2 cases (1.3%), the case was deferred for examination of the glass slides by the reviewing pathologists at University Medical Center.
  • We conclude that the virtual slide telepathology QA program found a small number of significant diagnostic discrepancies.
  • The virtual slide telepathology program service increased the job satisfaction of subspecialty pathologists without special training in breast pathology, assigned to cover the general surgical pathology service at a small satellite university hospital.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ReprintOf] Hum Pathol. 2009 Aug;40(8):1082-91 [19552938.001]
  • (PMID = 20069779.001).
  • [ISSN] 0740-2570
  • [Journal-full-title] Seminars in diagnostic pathology
  • [ISO-abbreviation] Semin Diagn Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


91. Egervari K, Toth J, Nemes Z, Szollosi Z: An alternative and reliable real-time quantitative PCR method to determine HER2/neu amplification in breast cancer. Appl Immunohistochem Mol Morphol; 2009 May;17(3):247-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The ways of measuring the copy number of the HER-2/neu gene in tumor cells comprise in situ hybridization techniques and real-time polymerase chain reaction (PCR).

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19098680.001).
  • [ISSN] 1533-4058
  • [Journal-full-title] Applied immunohistochemistry & molecular morphology : AIMM
  • [ISO-abbreviation] Appl. Immunohistochem. Mol. Morphol.
  • [Language] ENG
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gastrins; EC 2.7.10.1 / Receptor, ErbB-2
  •  go-up   go-down


92. Górski B, Cybulski C, Huzarski T, Byrski T, Gronwald J, Jakubowska A, Stawicka M, Gozdecka-Grodecka S, Szwiec M, Urbański K, Mituś J, Marczyk E, Dziuba J, Wandzel P, Surdyka D, Haus O, Janiszewska H, Debniak T, Tołoczko-Grabarek A, Medrek K, Masojć B, Mierzejewski M, Kowalska E, Narod SA, Lubiński J: Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat; 2005 Jul;92(1):19-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / genetics. Cell Cycle Proteins / genetics. Genes, BRCA1. Nuclear Proteins / genetics. Protein-Serine-Threonine Kinases / genetics
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Alleles. Checkpoint Kinase 2. Female. Genetic Predisposition to Disease. Humans. Middle Aged. Poland / epidemiology. Prevalence. Risk. Risk Assessment

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15980987.001).
  • [ISSN] 0167-6806
  • [Journal-full-title] Breast cancer research and treatment
  • [ISO-abbreviation] Breast Cancer Res. Treat.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / NBN protein, human; 0 / Nuclear Proteins; EC 2.7.1.11 / Checkpoint Kinase 2; EC 2.7.11.1 / CHEK2 protein, human; EC 2.7.11.1 / Protein-Serine-Threonine Kinases
  •  go-up   go-down


93. Desgranges C, Delhommelle J: Molecular simulation of the crystallization of aluminum from the supercooled liquid. J Chem Phys; 2007 Oct 14;127(14):144509
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular simulation of the crystallization of aluminum from the supercooled liquid.
  • We report hybrid Monte Carlo molecular simulation results on the crystallization of aluminum from the supercooled liquid.
  • We simulate the entire crystallization process at P=1 atm and at temperatures 20% and 15% below the melting temperature.
  • We demonstrate that crystallization takes place according to the same mechanism for the two degrees of supercooling considered in this work.
  • We show that both nucleation and growth proceed into a random mixing of the hexagonal close packed structure and of the face centered cubic (fcc) phase, with a predominance of the stable fcc form.
  • The concentration of icosahedral (Ih)-like atoms in the supercooled liquid is found to remain constant throughout nucleation and growth, showing that Ih-like atoms do not play an active role in the crystallization process.
  • We also find that the crystallization mechanism of aluminum differs from that observed for simple fluids.
  • While nucleation of simple fluids first proceeds into the metastable body centered cubic (bcc) phase, the fraction of bcc-like atoms in aluminum crystallites always remains very low.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17935411.001).
  • [ISSN] 0021-9606
  • [Journal-full-title] The Journal of chemical physics
  • [ISO-abbreviation] J Chem Phys
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. Karen JK, Gareau DS, Dusza SW, Tudisco M, Rajadhyaksha M, Nehal KS: Detection of basal cell carcinomas in Mohs excisions with fluorescence confocal mosaicing microscopy. Br J Dermatol; 2009 Jun;160(6):1242-50
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detection of basal cell carcinomas in Mohs excisions with fluorescence confocal mosaicing microscopy.
  • Nuclear and cellular morphology is observed in thin optical sections, similar to that in conventional histology.
  • OBJECTIVES: To evaluate the sensitivity and specificity of ex vivo real-time imaging with fluorescence confocal mosaicing microscopy, using acridine orange, for the detection of residual basal cell carcinoma (BCC) in Mohs fresh tissue excisions.
  • Very good correlation was observed between confocal mosaics and matched Mohs frozen sections for benign and malignant skin structures, overall tumour burden and location, and identification of all major histological subtypes of BCC.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Mohs Surgery / methods. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surgery. 2000 Dec;128(6):1088-1100; discussion 1100-1 [11114647.001]
  • [Cites] J Microsc. 2009 Jan;233(1):149-59 [19196421.001]
  • [Cites] Arch Dermatol. 2004 Jun;140(6):736-42 [15210467.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2004 Aug;130(8):923-8 [15313861.001]
  • [Cites] J Cell Biol. 1985 Apr;100(4):1309-23 [3920227.001]
  • [Cites] Dermatol Surg. 2004 Dec;30(12 Pt 1):1470-8 [15606734.001]
  • [Cites] J Biomed Opt. 2005 May-Jun;10(3):034009 [16229653.001]
  • [Cites] Br J Dermatol. 2006 Feb;154(2):305-9 [16433801.001]
  • [Cites] Opt Lett. 2006 Apr 1;31(7):942-4 [16599219.001]
  • [Cites] J Am Acad Dermatol. 2006 Sep;55(3):408-12 [16908344.001]
  • [Cites] Opt Lett. 2006 Sep 15;31(18):2756-8 [16936882.001]
  • [Cites] J Biomed Opt. 2007 Jan-Feb;12(1):014005 [17343480.001]
  • [Cites] Appl Opt. 2007 Apr 1;46(10):1843-51 [17356629.001]
  • [Cites] J Biomed Opt. 2007 May-Jun;12(3):034004 [17614712.001]
  • [Cites] J Biomed Opt. 2007 May-Jun;12(3):034027 [17614735.001]
  • [Cites] Lasers Surg Med. 2007 Oct;39(9):696-705 [17960751.001]
  • [Cites] J Biomed Opt. 2007 Sep-Oct;12(5):051901 [17994884.001]
  • [Cites] J Invest Dermatol. 2008 May;128(5):1248-55 [17989735.001]
  • [Cites] J Biomed Opt. 2008 Mar-Apr;13(2):024013 [18465976.001]
  • [Cites] Br J Dermatol. 2008 Jul;159(1):152-61 [18460029.001]
  • [Cites] J Biomed Opt. 2008 Jul-Aug;13(4):044016 [19021344.001]
  • [Cites] J Biomed Opt. 2008 Sep-Oct;13(5):054001 [19021381.001]
  • [Cites] J Invest Dermatol. 2001 Nov;117(5):1137-43 [11710924.001]
  • (PMID = 19416248.001).
  • [ISSN] 1365-2133
  • [Journal-full-title] The British journal of dermatology
  • [ISO-abbreviation] Br. J. Dermatol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA008748; United States / NIBIB NIH HHS / EB / R01 EB002715; United States / NIBIB NIH HHS / EB / R01 EB002715-05; United States / NIBIB NIH HHS / EB / R01EB002715
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ NIHMS95359; NLM/ PMC2693082
  •  go-up   go-down


95. Fullen DR, Garrisi AJ, Sanders D, Thomas D: Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays. J Cutan Pathol; 2008 Nov;35 Suppl 2:28-34
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Tissue microarrays of cutaneous epithelial neoplasms, mesenchymal neoplasms, DM and malignant peripheral nerve sheath tumors (MPNST) were stained with S100A6 antibody.
  • RESULTS: Eleven basal cell carcinomas (BCC) failed to express S100A6, whereas all 10 squamous cell carcinomas (SCC) expressed S100A6.
  • Malignant spindle cell tumors, with the exception of 13 of 30 MPNST, had a high incidence of S100A6 positivity.
  • [MeSH-major] Biomarkers, Tumor / analysis. Cell Cycle Proteins / biosynthesis. S100 Proteins / biosynthesis. Skin Neoplasms / diagnosis. Skin Neoplasms / metabolism
  • [MeSH-minor] Carcinoma, Basal Cell / diagnosis. Carcinoma, Basal Cell / metabolism. Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / metabolism. Diagnosis, Differential. Humans. Melanoma / diagnosis. Melanoma / metabolism. Neoplasms, Adnexal and Skin Appendage / diagnosis. Neoplasms, Adnexal and Skin Appendage / metabolism. Nerve Sheath Neoplasms / diagnosis. Nerve Sheath Neoplasms / metabolism. Tissue Array Analysis

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18201235.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cell Cycle Proteins; 0 / S100 Proteins; 105504-00-5 / S100A6 protein, human
  •  go-up   go-down


96. Han J, Cox DG, Colditz GA, Hunter DJ: The p53 codon 72 polymorphism, sunburns, and risk of skin cancer in US Caucasian women. Mol Carcinog; 2006 Sep;45(9):694-700
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The p53 gene is involved in the control of cell-cycle arrest and apoptosis.
  • We evaluated the association of the Arg72Pro polymorphism with skin cancer risk among Caucasians in a nested case-control study within the Nurses' Health Study (NHS) (219 melanoma, 286 squamous cell carcinoma (SCC), and 300 basal cell carcinoma (BCC) and 874 controls).
  • [MeSH-major] Codon / genetics. Genetic Predisposition to Disease. Skin Neoplasms / genetics. Sunburn / genetics. Tumor Suppressor Protein p53 / genetics

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • MedlinePlus Health Information. consumer health - Sun Exposure.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. (L)-ARGININE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16739124.001).
  • [ISSN] 0899-1987
  • [Journal-full-title] Molecular carcinogenesis
  • [ISO-abbreviation] Mol. Carcinog.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA09001-27; United States / NCI NIH HHS / CA / CA113100; United States / NCI NIH HHS / CA / CA87969
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Codon; 0 / Tumor Suppressor Protein p53; 94ZLA3W45F / Arginine
  •  go-up   go-down


97. Tsai TM, Wu YH, Yang KC, Yang CY, Tsai TH, Chan JY: Sebaceous carcinoma associated with seborrheic keratosis. J Cutan Med Surg; 2010 Sep-Oct;14(5):240-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The association of a seborrheic keratosis with other common cutaneous neoplasms such as basal cell carcinoma and Bowen disease has been reported, but the association between a seborrheic keratotis and a malignant neoplasm with sebaceous differentiation is very unusual.
  • OBJECTIVE: We present a case of two contiguous neoplasms, a seborrheic keratosis and a sebaceous carcinoma, and discuss the possibility of malignant change in a seborrheic keratosis as an explanation for the findings.
  • METHODS AND RESULTS: A 57-year-old man presented with an asymptomatic tumor on the skin of his abdomen that was composed of two separate but contiguous lesions.
  • CONCLUSION: Although the association is likely to be a coincidence and probably represents a collision tumor, the possibility that the sebaceous carcinoma represents malignant degeneration of the seborrheic keratosis cannot be entirely excluded.
  • [MeSH-major] Keratosis, Seborrheic / pathology. Sebaceous Gland Neoplasms / pathology

  • Genetic Alliance. consumer health - Keratosis, seborrheic.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20868621.001).
  • [ISSN] 1203-4754
  • [Journal-full-title] Journal of cutaneous medicine and surgery
  • [ISO-abbreviation] J Cutan Med Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


98. Sharma R, Tripathi M, Panwar P, Chuttani K, Jaimini A, Maitra S, Chopra MK, Sawroop K, Shukla G, Mondal A, Mishra A: 99mTc-methionine scintimammography in the evaluation of breast cancer. Nucl Med Commun; 2009 May;30(5):338-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: The diagnostic utility of a C-methionine scan has been established in breast cancer.
  • RESULTS: The histopathological findings were malignant in 33 (70%) and benign in 14 (30%) cases.
  • True-negative findings were found in 13 out of 14 patients having benign breast lesions.
  • [MeSH-major] Breast Neoplasms / radionuclide imaging. Methionine. Radiopharmaceuticals

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • Hazardous Substances Data Bank. (L)-Methionine .
  • Hazardous Substances Data Bank. TECHNETIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19282793.001).
  • [ISSN] 0143-3636
  • [Journal-full-title] Nuclear medicine communications
  • [ISO-abbreviation] Nucl Med Commun
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Carbon Radioisotopes; 0 / Radiopharmaceuticals; 7440-26-8 / Technetium; AE28F7PNPL / Methionine
  •  go-up   go-down


99. Wakai K, Kojima M, Nishio K, Suzuki S, Niwa Y, Lin Y, Kondo T, Yatsuya H, Tamakoshi K, Yamamoto A, Tokudome S, Toyoshima H, Tamakoshi A, JACC Study Group: Psychological attitudes and risk of breast cancer in Japan: a prospective study. Cancer Causes Control; 2007 Apr;18(3):259-67
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / psychology

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17334812.001).
  • [ISSN] 0957-5243
  • [Journal-full-title] Cancer causes & control : CCC
  • [ISO-abbreviation] Cancer Causes Control
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  •  go-up   go-down


100. Arias CR, Abernathy JW, Liu Z: Combined use of 16S ribosomal DNA and automated ribosomal intergenic spacer analysis to study the bacterial community in catfish ponds. Lett Appl Microbiol; 2006 Sep;43(3):287-92
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined use of 16S ribosomal DNA and automated ribosomal intergenic spacer analysis to study the bacterial community in catfish ponds.
  • AIMS: To apply culture-independent techniques to explore the bacterial community composition in catfish pond water.
  • METHODS AND RESULTS: 16S rDNA libraries were constructed and sequenced from 15 pond water samples.
  • Automated ribosomal intergenic spacer analysis (ARISA) was used to fingerprint each bacterial community.
  • A broad diversity in bacterial species composition was found by 16S rDNA analysis.
  • Alphaproteobacteria was the most represented class in all ponds, followed by Gammaproteobacteria and Gram-positive high G + C content bacteria.
  • Uniqueness of bacterial communities from each individual pond was confirmed by ARISA.
  • Catfish pathogens were detected sporadically.
  • CONCLUSIONS: Bacterial communities in a catfish aquaculture setting can vary from pond to pond at one given point.
  • No correlation could be made between bacteria composition and fish strain or between bacterial profile and the presence of catfish pathogens in a particular pond.
  • SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first report showing the composition of bacterial communities in catfish ponds.
  • Fish health specialists and catfish aquaculture managers should be aware of the wide differences in bacterial communities between ponds and include this variable in fish husbandry practices.
  • [MeSH-major] Bacteria / classification. Bacteria / isolation & purification. Catfishes / microbiology. DNA, Ribosomal Spacer / genetics
  • [MeSH-minor] Animals. Gene Library. RNA, Ribosomal, 16S / genetics. Ribotyping / instrumentation

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16910933.001).
  • [ISSN] 0266-8254
  • [Journal-full-title] Letters in applied microbiology
  • [ISO-abbreviation] Lett. Appl. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Ribosomal Spacer; 0 / RNA, Ribosomal, 16S
  •  go-up   go-down






Advertisement